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Atherosclerosis and specifically rupture of vulnerable plaques account for 23% of 
all deaths worldwide, far surpassing both infectious diseases and cancer. Plaque-based 
macrophages, often associated with lipid deposits, contribute to atherogenesis from 
initiation through progression, plaque rupture and ultimately, thrombosis. Therefore, the 
macrophage is an important early cellular marker related to vulnerability of 
atherosclerotic plaques. The objective of my research is to assess the ability of multiple 
optical imaging modalities to detect, and further characterize the distribution of 
macrophages (having taken up plasmonic gold nanoparticles as a contrast agent) and lipid 
deposits in atherosclerotic plaques. 
Tissue phantoms and macrophage cell cultures were used to investigate the 
capability of nanorose as an imaging contrast agent to target macrophages. Ex vivo aorta 
segments from a rabbit model of atherosclerosis after intravenous nanorose injection 
were imaged by optical coherence tomography (OCT), photothermal imaging (PTW) and 
two-photon luminescence microscopy (TPLM), respectively. OCT images depicted 
 viii 
detailed surface structure of atherosclerotic plaques. PTW images identified nanorose-
loaded macrophages (confirmed by co-registration of a TPLM image and corresponding 
RAM-11 stain on a histological section) associated with lipid deposits at multiple depths. 
TPLM images showed three-dimensional distribution of nanorose-loaded macrophages 
with a high spatial resolution. Imaging results suggest that superficial nanorose-loaded 
macrophages are distributed at shoulders on the upstream side of atherosclerotic plaques 
at the edges of lipid deposits. Combination of OCT with PTW or TPLM can 
simultaneously reveal plaque structure and composition, permitting assessment of plaque 
vulnerability during cardiovascular interventions. 
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Chapter  1 Introduction 
1.1 MOTIVATION 
Cardiovascular disease (CVD) remains the leading cause of deaths worldwide [1]. 
Mortality data show that CVD as the underlying cause of death (including congenital 
cardiovascular defects) accounted for 33.6% (813,804) of all 2,423,712 deaths in 2007 or 
1 of every 3 deaths in the United States [2]. The American Heart Association estimated 
the total direct and indirect cost of CVD in the United States for 2010 was $503.2 billion 
[3] or about 3.5% of the GDP. Atherosclerosis, one of  the most common CVD, can lead 
to myocardial infarction, stroke and progression of peripheral artery disease. The 
American Heart Association recognizes six stages of an atherosclerotic lesion [4]: Type I 
lesions are present even in children, and are composed of isolated foam cells in the 
arterial wall. Type II lesions are also known as fatty streak lesions and feature more foam 
cells. Type III lesions feature pools of fatty material located outside the cells, and can be 
present in young adults. Type IV lesions are called atheromas (atherosclerotic plaques) 
and have a core of cell-free lipid (fat). Type V lesions are known as fibroatheromas and 
are surrounded by fibrous tissue and may also contain calcifications, which make the 
arteries remarkably hard and inflexible. Type V lesions are present in older adults. Type 
VI lesions are complicated and include surface defects, blood clotting activity, and may 
result in formation of blood clots that can break off and be transported to other parts of 
the body by the blood stream. Although the disease process tends to be slow and progress 
over decades, conditions usually remain asymptomatic until an atheroma ruptures, which 
leads to immediate blood clotting at the site of atheroma rupture. Plaque rupture triggers 
a cascade of events that leads to clot enlargement, which may quickly obstruct the flow of 
blood. A complete blockage leads to ischemia of the myocardial (heart) muscle and 
damage. This process is termed a myocardial infarction or "heart attack". In 2004, 
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approximately 157,000 heart attacks were fatal in the United States [5]. One study 
indicated that approximately half of cardiac deaths occur within one hour of symptom 
onset, before patients reach a hospital [6].  
Many of the cellular and molecular events that lead to rupture of atherosclerotic 
plaques, thrombus formation and consequent acute myocardial infarction are now 
understood and being utilized to develop novel imaging approaches. Several features of 
the inflammatory process have been identified that contribute to mechanical instability 
and increased risk of plaque remodeling and subsequent rupture. For instance, 
accumulations of macrophages in atherosclerotic plaques over-express matrix 
metalloproteinases (MMPs), such as MMP-1 (collagenase-1), MMP-3 (stromelysin-1), 
and MMP-9 (gelatinase-B) [7-10]. Over-expression of such matrix-degrading enzymes is 
believed to contribute to instability of atherosclerotic plaques and thrombogenicity [11-
13]. Therefore, the macrophage is an important early cellular marker that indicates and 
contributes to increased risk of plaque remodeling and subsequent rupture in the 
coronary, cerebral, and peripheral circulations. 
Inasmuch as atherosclerosis is an inflammatory disease of the arterial wall, ability 
to identify macrophages in vulnerable atherosclerotic plaques before rupture is a 
cornerstone of early diagnosis. Currently, many imaging modalities have been 
investigated to detect vulnerable plaques. Non-invasive imaging modalities include 
magnetic resonance imaging (MRI), computed tomography (CT) and positron-emission 
tomography (PET). Catheter-based minimally-invasive imaging modalities include near-
infrared fluorescence (NIRF) imaging, intravascular ultrasound (IVUS), intravascular 
photoacoustic imaging (IVPA) and intravascular optical coherence tomography (IVOCT) 
[14-19]. However, none of these approaches has been used to image macrophages in 
vulnerable plaques with high resolution, high sensitivity and high specificity. Therefore, 
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development of a diagnostic imaging technique that can simultaneously reveal both 
plaque cellular composition (e.g., macrophages) and anatomical structure is critical to 
identify vulnerable plaques and would allow the determination of macrophage density in 
longitudinal studies in response to therapies without cutting tissue. Moreover, clinical 
validation of such an imaging technique would enable detection and treatment of 
atherosclerotic plaques at an early stage and, thus, reduce the risk of future myocardial 
infarction. 
1.2 RESEARCH OBJECTIVES 
The principal goal of my research is to develop hybrid optical imaging modalities 
(i.e., photothermal wave (PTW) imaging combined with optical coherence tomography 
(OCT), two-photon luminescence microscopy (TPLM) combined with OCT), and assess 
the ability of such hybrid imaging modalities to reveal both cellular composition (e.g., 
macrophages (having taken up plasmonic gold nanoparticles as a contrast agent) and lipid 
deposits) and anatomical structure of atherosclerotic plaques.  
Objectives of my research are achieved through the following specific aims: 
(1) Measure the optical properties of nanorose as an imaging contrast agent for 
PTW imaging to target macrophages. 
(2) Investigate dual-wavelength multi-frequency/swept-frequency PTW imaging 
in detecting macrophages and lipid deposits in tissue phantoms and ex vivo 
tissues. 
(3) Investigate the capability of PTW imaging combined with OCT to detect 
nanorose-loaded macrophages associated with lipid deposits at multiple 
depths in atherosclerotic plaques with respect to plaque surface structure. 
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(4) Investigate the capability of TPLM combined with OCT to detect and 
characterize the three-dimensional distribution of nanorose-loaded 
macrophages in atherosclerotic plaques with respect to plaque surface 
structure with a higher spatial resolution compared to PTW imaging. 
1.3 DISSERTATION OVERVIEW   
The dissertation is structurally divided into four parts. The first part reviews 
current imaging modalities and imaging contrast agent for atherosclerosis detection and 
targeting (Chapter 2). The second part characterizes the optical properties of nanorose as 
a contrast agent for PTW imaging to target macrophages (Chapter 3). The third part of 
the dissertation describes macrophage detection using PTW imaging and fluorescence 
imaging (Chapters 4 and 5). The fourth part investigates the combination of PTW 
imaging/TPLM with OCT to reveal both cellular composition (e.g., macrophages and 
lipid deposits) and anatomical structure of atherosclerotic plaques (Chapters 6 and 7).  
In detail, Chapter 2 describes the current status of CVD and pathophysiology of 
atherosclerosis. Moreover, current imaging techniques for diagnosing atherosclerosis and 
clinical/pre-clinical imaging contrast agents for atherosclerosis targeting are reviewed. 
Chapter 3 describes experimental and simulation procedures of nanorose 
absorption (σa) and scattering (σs) cross-section measurements. From experimental 
measurements, σa was computed (mean = 3.1 × 10-14 m2, standard deviation = 0.5 × 10-14 
m2). Data suggested that σs is much smaller than σa and beyond the sensitivity of our 
measurements. Discrete dipole approximation (DDA) simulation results showed that σa / 
σs = 10.5 for a randomly generated nanorose cluster geometry (30 nm in diameter, 60 
gold-coated iron oxide nanoparticles). The ratio of absorption to scattering cross-sections 
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(σa / σs) from DDA simulation is consistent with our experimental results ( published in 
ACS Nano (Ma LL, Wang T, et al, 2009), OSA Technical Digest (Wang T, et al, 2010)). 
Chapter 4 introduces three different applications of PTW imaging: (1) fixed-
frequency PTW imaging of macrophages and lipid deposits in ex vivo tissues. PTW 
amplitude images were obtained corresponding to 800 nm and 1210 nm laser irradiation. 
Computed images suggest that the distributions of both nanorose and lipid can be 
identified in amplitude images at a frequency of 4 Hz. Nanoroses taken up by 
macrophages are distributed at the edges of lipid deposits. Observation of high 
concentration of nanoroses in atherosclerotic plaque confirms that nanoroses are present 
at locations associated with lipid deposits (published in Proc SPIE (Wang T, et al, 
2010)). (2) multi-frequency PTW imaging of lipid deposits in ex vivo tissues. The 1210 
nm excitation wavelength was selected to target lipids. The atherosclerotic plaque sample 
was irradiated at modulation frequencies ranging from 0.1 to 5 Hz to generate PTWs. 
Amplitude and phase images obtained at each modulation frequency were related to 
lateral and depth distribution of lipid in the atherosclerotic tissue samples. PTW images 
recorded from the atherosclerotic plaque suggest that lateral and depth distribution of 
lipid can be identified by analysis of amplitude and phase images at selected modulation 
frequencies. The geometric shape of atherosclerotic plaque is associated with distribution 
of the lipid deposits (published in Proc BMES (Wang T, et al, 2010)). (3) swept-
frequency PTW imaging of nanorose in tissue phantoms. The excitation wavelength of 
800 nm was selected to target nanorose. Tissue phantoms were irradiated at modulation 
frequencies ranging from 0.04 to 5 Hz to generate PTWs. PTW images recorded from 
tissue phantoms suggest that three-dimensional distribution of nanorose can be identified 
by analysis of amplitude and phase images at selected modulation frequencies. Swept-
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frequency PTW imaging is able to detect nanoroses as deep as 930 µm (abstract 
published in Lasers Surg Med (Wang T, et al, 2010)). 
Chapter 5 explores fluorescence imaging of macrophages in atherosclerotic 
plaques using plasmonic gold nanorose. A HeNe laser at 633 nm was used as an 
excitation light source and an acousto-optic beam splitter was utilized to collect 
fluorescence emission in the 650-760 nm spectral range. Results of scanning confocal 
microscopy of macrophage cell cultures and ex vivo arterial tissue showed that nanoroses 
produce a strong fluorescence signal. The presence of nanorose in ex vivo arterial tissue 
was further confirmed by PTW imaging. These results suggest that scanning confocal 
microscopy can identify the presence and location of nanorose-loaded macrophages in 
atherosclerotic plaques (published in Proc SPIE (Wang T, et al, 2011)). 
Chapter 6 assesses the ability of combined dual-wavelength multi-frequency PTW 
imaging and OCT to detect, and further characterize the distribution of macrophages 
(having taken up plasmonic gold nanorose) and lipid deposits in atherosclerotic plaques. 
Amplitude PTW images (4 Hz) were merged into a co-registered OCT image, suggesting 
that superficial nanorose-loaded macrophages are distributed at shoulders on the 
upstream side of atherosclerotic plaques (P<0.01) at edges of lipid deposits. Results 
suggest that combined PTW-OCT imaging can simultaneously reveal plaque structure 
and composition, permitting characterization of nanorose-loaded macrophages and lipid 
deposits in atherosclerotic plaques (published in J Biomed Opt (Wang T, et al, 2012)). 
Chapter 7 investigates the ability of combined TPLM and OCT for macrophage 
detection in the hypercholesterolemic rabbit aorta using plasmonic gold nanorose. 
Merged two-channel TPL images suggest that nanorose-loaded macrophages are 
diffusively distributed and mostly detected superficially within 20 µm from the luminal 
surface of the aorta. OCT images depict detailed surface structure of the diseased aorta. 
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Results suggest that TPLM combined with OCT can simultaneously reveal macrophage 
distribution with respect to aorta surface structure, which has the potential to detect 
vulnerable plaques and monitor plaque-based macrophages overtime during 
cardiovascular interventions (published in Lasers Surg Med (Wang T, et al, 2012)). 
Chapter 8 presents conclusions and directions for future studies related to my 
dissertation research. Several potential research directions are proposed and outlined.  
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Chapter  2 Background 
This chapter provides a brief overview of the current status of cardiovascular 
disease and pathophysiology of atherosclerosis. Subsequently, current imaging 
techniques for diagnosing atherosclerosis and clinical/pre-clinical imaging contrast agents 
for atherosclerosis targeting are reviewed. 
2.1  CARDIOVASCULAR DISEASE 
2.1.1 Current Status of Cardiovascular  Disease 
Cardiovascular disease (CVD) or heart disease is a class of diseases that involve 
the heart or blood vessels (arteries and veins) [1]. While the term technically refers to any 
disease that affects the cardiovascular system, the term is usually used to refer to those 
conditions related to atherosclerosis.  
CVD remains the leading cause of deaths worldwide [2]. Figure 2.1 shows the 
global distribution of CVD mortality rates in males and females reported by the World 
Health Organization (WHO) [3]. According to WHO estimates, in 2002, 16.7 million 
people around the globe died of CVD [4]. In the United States, CVD accounted for 
33.6% (813,804) of all 2,423,712 deaths or 1 of every 3 deaths in 2007 [5]. Figure 2.2 
shows the death rate in males and females for total CVD and total deaths in selected 
countries reported by WHO [4]. By 2020, CVD and stroke is expected to become the 
leading cause of both death and disability worldwide, with the number of fatalities 
projected to increase to over 20 million a year and by 2030 to over 24 million a year [6].  
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Figure 2.1. (a)  World map showing the global distribution of CVD mortality rates in 
males (age standardized, per 100,000). (b) World map showing the global distribution of 




Figure 2.2. Death rate in males (left) and females (right) for total CVD and total 
deaths in selected countries. Figure adapted from [4]. 
2.1.2 Pathophysiology of Atherosclerosis 
Atherosclerosis and plaque rupture leads to myocardial infarction, stroke and 
progression of peripheral artery disease. Atherosclerotic lesions (plaques) are asymmetric 
focal thickenings of the innermost layer of the artery - the intima. Plaques consist of cells, 
connective-tissue elements, lipids and debris. An atherosclerotic plaque is preceded by a 
fatty streak, an accumulation of lipid-laden cells beneath the endothelium. Most of these 
cells in the fatty streak are macrophages, together with some T cells [7]. Many 
investigators once believed that progressive luminal narrowing or stenosis beginning 
from increased lipid storage and continued growth of smooth-muscle cells in the plaque 
was the main cause of myocardial infarction [8]. Recent advances in basic and 
experimental science have established a fundamental role that inflammation and 
underlying cellular and molecular mechanisms [9-11] contribute to atherogenesis from 
initiation through progression, plaque rupture and ultimately, thrombosis. The principal 
pathologic features and progression stages (see Section 1.1) of atherosclerotic plaques 
that are prone to rupture are now well described (Figure 2.3) [12].  
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Figure 2.3. The development of an atherosclerotic plaque. The progression of an 
atherosclerotic lesion is shown in a simplified form, developing from a normal blood 
vessel (far left) to a vessel with an atherosclerotic plaque and superimposed thrombus (far 
right). Potential targets for molecular imaging at each stage are also listed. AHA, 
American Heart Association; ICAM1, intercellular adhesion molecule 1; LDL, low-
density lipoprotein; MMP, matrix metalloproteinase; VCAM1, vascular cell-adhesion 
molecule 1. Figure adapted from [12]. 
Davies and colleagues noted that with the reconstruction of serial histological 
sections in individuals suffering from acute myocardial infarctions associated with death, 
a rupture or fissuring of “vulnerable plaque” was evident [13]. Vulnerable plaques, 
recently defined by Virmani [14] using a more descriptive term “thin-cap fibroatheroma”, 
were further characterized as having a thin fibrous cap typically less than 65 µm thick, 
increased infiltration of macrophages with decreased smooth muscle cells, and an 
increased lipid core size when compared to stable plaques [15-17].  
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Many of the cellular and molecular events that lead to rupture of thin-cap 
fibroatheromas, thrombus formation and consequent acute myocardial infarction are 
understood and being utilized to develop novel imaging approaches. Several features of 
the inflammatory process have been identified that contribute to mechanical instability 
and increased risk of plaque remodeling and subsequent rupture, including: infiltration 
and retention of low-density lipoprotein (LDL) [18-19], activation of endothelial cells 
[20], over-expression of adhesion molecules such as vascular cell adhesion molecule 1 
(VCAM-1) and chemokines [21-22], activation and recruitment of macrophages [23-25], 
a decrease in smooth muscle cells (SMCs) and collagen synthesis [26-27], and thinning 
of the fibrous cap overlying a large lipid core [28]. Accumulations of macrophages in 
atherosclerotic plaques over-express matrix metalloproteinases (MMPs), such as MMP-1 
(collagenase-1), MMP-3 (stromelysin-1), and MMP-9 (gelatinase-B) [29-32]. Over-
expression of such matrix-degrading enzymes is believed to contribute to instability of 
thin-cap fibroatheromas and increase thrombogenicity [33-35]. Therefore, the 
macrophage is an important early cellular marker that indicates and contributes to 
increased risk of plaque remodeling and subsequent rupture in the coronary, cerebral, and 
peripheral circulations. 
2.2  DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS 
2.2.1 Current Imaging Modalities for  Atherosclerosis Detection 
Traditionally, diagnosis of atherosclerosis was possible only at advanced stages of 
lesions by directly revealing the morphological changes of blood vessels (e.g., narrowing 
of the vessel lumen). However, new imaging approaches allow the assessment not only of 
the morphology of blood vessels but also of the composition of the vessel walls, enabling 
observation of atherosclerosis-associated pathological alterations in the arteries, down to 
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the cellular and molecular level in some cases. Some of these approaches are now in 
clinical use or are being tested in clinical trials, whereas others are better suited to basic 
and translational research. In this section, recent advances in imaging modalities for 
atherosclerosis detection are discussed. First, non-invasive imaging techniques (i.e., 
computed tomography (CT), magnetic resonance imaging (MRI), positron emission 
tomography (PET) and single-photon-emission CT (SPECT)) are described. Then the 
growing field of minimally-invasive imaging techniques (i.e., intravascular ultrasound 
(IVUS), intravascular photoacoustic imaging (IVPA), fluorescence lifetime imaging 
(FLIM), intravascular optical coherence tomography (IVOCT)) and invasive microscopic 
techniques (i.e., non-linear optical microscopy (NLOM)) are investigated. 
As lipids presents lower X-ray absorption, atherosclerotic plaques can be 
characterized by CT as hypo-dense, dense or calcified [36]. Recently, CT has been 
demonstrated to detect macrophages in the blood vessel wall using an iodinated 
nanoparticulate contrast agent [37]. Similarly, MRI is also able to depict plaque presence, 
size and morphology but without exposing the patient to ionizing radiation like CT [38]. 
Although MRI can achieve macrophage imaging [39-40], relatively large amounts of 
contrast agents (2 to 20 mg Fe/kg) are required. PET, however, provides detection 
sensitivities an order of magnitude higher than MRI, enabling the use of radioactive 
contrast agent at lower concentrations. The combination of PET and CT has the potential 
to map macrophage infiltration onto anatomic vascular structures [41-42]. SPECT 
presents comparable sensitivity to PET, but also requires the use of radioactive contrast 
agent to track macrophage recruitment to atherosclerotic plaques [43].  
Intravascular imaging techniques are minimally-invasive. IVUS can perform 
virtual histology by using spectral analysis to identify plaque components [44-45]. By 
detecting laser-induced thermal expansion ultrasonically, IVPA is able to map 
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macrophages onto an IVUS image using contrast agent [46]. FLIM is used to measure the 
autofluorescence and can assess the biochemical composition (e.g., MMPs) of 
atherosclerotic plaques [47]. IVOCT has been demonstrated to visualize microstructural 
features atherosclerotic plaques with high resolution [48-51] and is currently the sole 
approach that provides sufficient spatial resolution to image thin-cap fibroatheromas in 
vivo.  
NLOM including two-photon luminescence microscopy (TPLM), second 
harmonic generation (SHG) and coherent antistokes Raman scattering (CARS) 
microscopy uses nonlinear optical properties of tissue and has been recently utilized to 
image plaque components such as endothelial cells, smooth muscle cells [52], elastin 
fibers [53-54], oxidized LDL [55] and lipid droplets [56] based on their endogenous 
autofluorescence. Up to now, NLOM provides the highest spatial resolution than other 
cardiovascular imaging techniques despite its invasive nature.  
A comparison of penetration depth, spatial resolution and temporal resolution of 









CT several cm 0.1-0.29 mm/0.1-1 mm ~10 fps 
MRI several cm 0.04-0.5 mm/0.3-0.5 mm ~30 fps 
PET several cm 1-4 mm/1-4 mm <5 fps 
SPECT several cm 3 mm/3 mm <1 fps 
IVUS 4-7.6 mm 100 μm/20-50 μm 30 fps 
IVPA 3 mm 100 μm/25 μm 1 fps 
FLIM superficial 100 μm/NA 10 fps 
IVOCT 1-2 mm 10 μm/10-20 μm 60 fps 
TPLM 200 μm 0.3 μm/1 μm < 50 fps 
SHG 550 μm 0.5 μm/1-1.9 μm < 50 fps 
CARS 500 μm 0.5 μm/1 μm < 50 fps 
Table 2.1. Comparison of cardiovascular imaging techniques in terms of penetration 
depth, spatial resolution and temporal resolution. 
Although CT/MRI/PET/SPECT can assess atherosclerosis non-invasively, 
IVUS/IVOCT have higher spatial and temporal resolution, IVPA/FLIM can obtain 
plaque biochemical information, none of these techniques is able to provide cellular or 
subcellular resolution. TPLM/SHG/CARS are superior in terms of spatial resolution, 
however, endogenous fluorescence contrast does not provide sufficient specificity to 
target macrophages in atherosclerotic plaques. Therefore, an imaging technique that can 
reveal both plaque cellular composition (e.g., macrophages and lipid deposits) and 
anatomical structure with high resolution, sensitivity and specificity is of great interest 
for clinical applications. 
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2.2.2 Medical Treatment of Atherosclerosis 
Atherosclerosis treatment usually begins with lifestyle changes, such as a healthy 
diet, exercising regularly, cessation of smoking, and maintaining a healthy body weight 
[65-72]. In addition, medications or surgical procedures may be undertaken. Various 
pharmacological interventions can slow, or even reverse the effects of atherosclerosis, 
including: cholesterol reduction, anti-platelet, beta-blockers, angiotensin-converting 
enzyme inhibitors, calcium channel blockers and diuretics [73]. Specifically, clinical 
trials have shown that lipid lowering by 3-hydroxy-3-methylglutaryl coenzyme A (HMG-
CoA) reductase inhibitors or statins can reduce acute coronary events and mortality rates 
in many individuals [74-77]. More aggressive interventions including surgery may be 
needed if severe symptoms are observed, these include: angioplasty, stenting, 
endarterectomy, thrombolytic therapy and bypass surgery [78]. Although coronary 
angioplasty can immediately reduce anginal symptoms in almost all patients undergoing 
therapy, use is associated with nonfatal myocardial infarction or death in about 5% of 
patients [79-82]. Moreover, restenosis requiring repeated angioplasty or bypass surgery 
occurs in about 30% [83] of these patients. Several clinical trials have shown that the 
deployment of coronary stents reduces the occurrence of acute complications and 
restenosis in patients undergoing coronary angioplasty [84-85]. However, the use of 
stents as a “plaque sealing” approach was recently criticized by Nissen, arguing that 
atherosclerosis is fundamentally a systemic inflammatory disease [86]. Nissen suggests 




 2.3  IMAGING CONTRAST AGENTS FOR ATHEROSCLEROSIS TARGETING 
2.3.1 A Review of Currently Used Contrast Agents 
In the past decade, cardiovascular imaging has advanced from merely imaging 
vascular anatomy and physiology to detecting biological processes at the cellular or even 
molecular level, which relies on the development in three scientific fields: 1) imaging 
platforms, 2) molecular epitope and ligand identification, and 3) design and use of high-
quality contrast agents. As far as the latter is concerned, significant progress is being 
made for tracking potentially important components of atherosclerotic disease [87-92]. 
Nano-sized contrast agents provide many advantages over conventional approaches [91]: 
1) significant signal amplification due to a number of imaging labels or a conbination of 
labels attached to a single nanoparticle, 2) enhanced binding affinity and specificity by 
conjugating multiple targeting ligands onto the nanoparticle, and 3) better targeting 
efficacy by bypassing biological barriers. Currently, most of the available contrast agents 
are in laboratory testing (especially for optical imaging), although some have already 
advanced to clinical evaluation and routine use (e.g., for MRI, CT, PET, SPECT). Table 
2.2 summarizes currenly developed contrast agents, their cellular or molecular targets and 
applications in various imaging modalities. 
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Table 2.2. Cellular/molecular targets and contrast agents for atherosclerosis imaging. 
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2.3.2 A Novel Contrast Agent: Nanorose 
As no endogenous optical absorption or scattering contrast exists between 
macrophages and other plaque components, in this research, a novel gold nanoparticle 
called nanorose was utilized to serve as a macrophage targeting chromophore [115]. The 
nanoclusters were formed by kinetic assembly of gold/iron oxide nanocomposite building 
blocks with only a small amount of polymeric stabilizers. The closely spaced and 
asymmetric thin gold coatings on the primary particles and porosity of the nanoclusters 
favor high NIR absorbance as a result of collective responses of the electrons and reduced 
symmetry of the interactions between plasmon modes. The details of nanorose optical 
properties and synthesis procedure are discussed in Chapters 3, 5, 6 and 7. 
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Chapter  3 Optical Proper ties of Nanorose1
3.1  ABSTRACT 
 
Nanorose is used to target macrophages in atherosclerotic plaques. Experimental 
measurement and simulation of nanorose absorption (σa) and scattering (σs) cross-sections 
give, respectively, σa = (3.1±0.5)×10-14 m2 and σa/σs = 10.5. 
3.2 INTRODUCTION 
Atherosclerosis and specifically rupture of vulnerable plaques leading to 
myocardial infarction and stroke remain the leading cause of death worldwide [1]. In 
atherosclerosis, macrophages can infiltrate plaques which are often associated with lipid 
deposits. Nanorose (taken up by macrophages via endocytosis) is a spectrally-tunable 
optical nanoaggregate, which has an average diameter of 30 nm and consists of thin gold 
shell coated iron oxide nanoparticles [2]. Intense NIR (700-850 nm) absorbance makes 
nanorose a candidate marker for targeting macrophages in atherosclerotic plaques using 
imaging techniques based on photo-absorption [3]. A direct optical properties 
measurement technique can be used to measure σa and σs of nanorose solution [4]. In 
comparison, the discrete-dipole-approximation (DDA) [5] can be utilized to simulate 
light interaction with a single nanorose cluster and calculate σa and σs of a nanorose. The 
purpose of this study is to experimentally measure σa and σs of nanorose and compare 
with results from DDA simulation. 
                                                 
1 Significant portions of this chapter has been previously published in ACS Nano 3(9), 2686–2696 (2009) 
and OSA Technical Digest, JWA12 (2010). 
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3.3 MATERIALS AND METHODS 
3.3.1 Direct Measurement 
A lens coupled fiber optic laser (Opto Power, Inc.; Model FCTS/B) was used to 
irradiate a nanorose sample solution  positioned inside an integrating sphere (Figure 
3.1). The nanorose sample solution was positioned in a glass sample holder and consisted 
to two microscope slides displaced by 80 µm. The sample holder was positioned in the 
center of the integrating sphere and oriented perpendicular to the incident laser beam 
(3W, 800nm, CW mode). A power meter (Newport, Inc.; Model 1935-C) was placed at a 
port of the integrating sphere oriented perpendicular to the laser beam. For absorption 
coefficient (µa) measurement, radiant power was measured with the sample holder 
containing deionized water and nanorose solution. The directly transmitted beam through 
the sample holder was contained within the integrating sphere and contributed to the 
measurement. For scattering coefficient (µs) measurement, the same procedure was 
followed except that the non-scattered directly transmitted beam was allowed to exit the 
integrating sphere and did not contribute to the measurement. Samples were prepared at 
six nanorose concentrations (385, 193, 96, 77, 39 and 26 µg Au/ml) with corresponding 
nanorose number densities N = 1.2 × 1011, 0.6 × 1011, 0.4 × 1011, 0.24 × 1011, 0.12 × 1011 
and 0.08 × 1011 nanoroses/ml, respectively. Absorption coefficient and scattering 
coefficient were computed using equations µa =  (1/l)·(Ia0 - Ia) / Ia0 and µs =  (1/l)·(Is / Is0). 
Where l = 80 µm is nanorose solution sample thickness; I·0 (W) and I· (W) represent, 
respectively, the measured radiant power with deionized water and nanorose solution. 
Subscripts a and s represent absorption and scattering coefficient measurements. 
Absorption and scattering cross-sections were then computed by equations σa = µa / N and 
σs = µs / N. 
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Figure 3.1. Experimental setup for absorption and scattering cross-sections 
measurement. 
3.3.2 Discrete Dipole Approximation 
Dipole array representation for a nanorose cluster geometry (30 nm in diameter, 
60 gold-coated iron oxide nanoparticles) was created (Figure 3.2) and loaded into a DDA 
program (DDSCAT 7.0) and absorption and scattering cross-sections were calculated. 
 
Figure 3.2. (a) A cross-section image of nanorose geometry used in DDA. (b) Cartoon 
of hypothetical nanorose geometry depicted from nanorose TEM image. 
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3.4 RESULTS AND DISCUSSION 
From experimental measurements, the absorption coefficient µa = 29.3, 19.2, 
10.3, 7.6, 4.2 and 2.9 cm-1, the corresponding absorption cross-section σa = 2.4 × 10-14, 
3.2 × 10-14, 2.6 × 10-14, 3.2 × 10-14, 3.5 × 10-14 and 3.6 × 10-14 m2 (mean = 3.1 × 10-14 m2, 
standard deviation = 0.5 × 10-14 m2) were computed from the six nanorose concentrations. 
Because the values of (Is / Is0) / e-µa·x for the six nanorose concentrations are close to 1 
(mean = 0.98, standard deviation = 0.03), data suggest that σs is much smaller than σa and 
beyond the sensitivity of our measurements. DDA simulation results show that σa / σs = 
10.5 for a randomly generated nanorose cluster geometry (30 nm in diameter, 60 gold-
coated iron oxide nanoparticles). The ratio of absorption to scattering cross-sections (σa / 
σs) from DDA simulation is consistent with our experimental results. 
DDA simulation gives smaller absorption cross-section than that determined from 
experiment, which suggests that actual nanorose structure may be different from the 
randomly generated nanorose cluster geometry in DDA. In fact, nanorose has a much 
more complicated shape and composition (Figure 3.2b). This complexity needs to be 
taken into account in further DDA simulations. For instance, some of the gold shell 
coated nanoparticles in nanorose are so closely arranged that those nanoparticles can take 
on a “nanorod-like” shape and be oriented side-by-side to neighboring nanoparticles. As 
a result, actual absorption and scattering cross-sections may be larger than computed 
values due to the plasmon coupling effect [6]. 
3.5 CONCLUSION 
The absorption and scattering cross-sections of nanorose are determined from a 
direct optical properties measurement and a DDA simulation. Experiment indicates that 
absorption cross-section is σa = (3.1 ± 0.5) × 10-14 m2. DDA results indicate that nanorose 
absorption cross-section is an order of magnitude larger than the scattering cross-section.  
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Chapter  4 Photothermal Wave (PTW) Imaging of Nanorose and Lipid2
4.1  FIXED-FREQUENCY PTW IMAGING OF MACROPHAGES AND LIPID DEPOSITS IN 
EX VIVO TISSUES 
 
4.1.1 Abstract 
Atherosclerosis and specifically rupture of vulnerable plaques account for 23% of 
all deaths worldwide, far surpassing both infectious diseases and cancer. In 
atherosclerosis, macrophages can infiltrate plaques which are often associated with lipid 
deposits. PTW imaging is based on the periodic thermal modulation of a sample using 
intensity modulated light. Intensity modulated light enters the sample and is absorbed by 
targeted chromophores and generates a periodic thermal modulation. We report use of 
PTW imaging to visualize nanoroses (taken up by macrophages via endocytosis) and 
lipids in atherosclerotic plaques. Two excitation wavelengths were selected to image 
nanoroses (800 nm) and lipids (1210 nm). Atherosclerotic plaque in a rabbit abdominal 
artery was irradiated (800 nm and 1210 nm separately) at a frequency of 4 Hz to generate 
PTWs. The radiometric temperature at the tissue surface was recorded by an infrared (IR) 
camera over a 10 second time period at the frame rate of 25.6 Hz. Extraction of images 
(256 × 256 pixels) at various frequencies was performed by Fourier transform at each 
pixel. Frequency amplitude images were obtained corresponding to 800 nm and 1210 nm 
laser irradiation. Computed images suggest that the distributions of both nanorose and 
lipid can be identified in amplitude images at a frequency of 4 Hz. Nanoroses taken up by 
macrophages are distributed at the edges of lipid deposits. Observation of high 
concentration of nanoroses in atherosclerotic plaque confirms that nanoroses are present 
at locations associated with lipid deposits. 
                                                 
2 Significant portions of this chapter has been previously published in Proc SPIE 7562, 75620S1-75620S7 
(2010), Proc BMES, OP-7-3-3A (2010), and Lasers Surg Med 42 (S22), 13 (2010). 
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4.1.2 Introduction 
Atherosclerosis and specifically rupture of vulnerable plaques leading to 
myocardial infarction, stroke and progression of peripheral artery disease remain the 
leading cause of death worldwide [1]. Vulnerable plaques are characterized as having a 
thin fibrous cap of less than 65 μm, increased infiltration of macrophages with decreased 
smooth muscle cells, and an increased lipid core size when compared to stable plaques 
[2]. Davies and coworkers noted that with the reconstruction of serial histological 
sections in patients with acute myocardial infarctions associated with death, a rupture or 
fissuring of vulnerable plaque was evident [3]. Further, greater macrophage density is 
associated with increased plaque vulnerability to rupture [4]. Thus, macrophages are an 
important early cellular marker that indicate and contribute to increased risk of plaque 
remodeling and subsequent rupture in the coronary, cerebral, and peripheral circulations. 
Nanorose used to target macrophages in this study is a spectrally-tunable optical 
nanoaggregates. The 30 nm diameter nanoroses are formed by kinetically controlled 
assembly of thin gold shell coated iron oxide nanoparticles in aqueous medium [5]. 
Intense NIR (700-850 nm) absorbance with an absorption cross-section of 3.1×10-14 m2 at 
a wavelength of 800 nm is achieved by the asymmetric core-shell geometry and 
collective effects from close spacing between primary particles in the clusters. Due to 
dextran coating, nanorose can be taken up by macrophages via endocytosis [6]. 
Therefore, macrophages are selectively targeted by nanorose. Since the absorbance 
spectrum of lipid and normal aortic tissue are known to nadir at 700-800 nm [7] while 
nanorose has an absorption peak at 800 nm; Moreover, the absorption of water is 
relatively small compared to lipid at 1210 nm [8], lasers at wavelengths of 800 nm and 
1210 nm are chosen to visualize nanorose and lipid respectively. PTW imaging is based 
on the periodic thermal modulation of a sample using intensity modulated light. Intensity 
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modulated light enters the sample and is absorbed by targeted chromophores and 
generates a periodic thermal modulation [9]. In this study, we propose using PTW 
imaging to visualize nanoroses and lipids in atherosclerotic plaques. 
4.1.3 Mater ials and Methods 
4.1.3.1 Preparation of Tissues 
A double-balloon injury procedure was performed at the bifurcation of the 
common iliacs on a New Zealand white rabbit. The rabbit was fed with high fat diet for 
two weeks after balloon injuries for the sake of atherosclerosis growth. The rabbit was 
then sacrificed three days after marginal ear vein injection with nanorose (1.4 mg 
nanorose/kg rabbit body weight). The aorta was harvested and flushed until there were no 
red blood cells. Then the aorta was placed in a specimen container with saline. The 
abdominal artery, which was 1 cm below diaphragm and 1 cm above bifurcation, was cut 
off because the double-balloon may not injure those segments. In the remaining 
abdominal artery, three segments (1.5 cm in length for each segment) were equally 
harvested and marked A1, A2 and A3 (Figure 4.1). All the procedure was performed 
using sterile equipment, supplies and aseptic technique. The animal protocol was 
approved by IACUC at the University of Texas Health Science Center at San Antonio. 
         
Figure 4.1. (a) Digital image of a piece of abdominal artery. (b) Top view infrared 
image of a segment on an abdominal artery before laser irradiation (surface in the image 
is intimal layer of the artery). 
1 cm 1 cm 
a b 
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4.1.3.2 PTW Theory and System 
PTW imaging has played an important role in the area of non-invasive evaluation 
of subsurface structures in tissue and tissue phantom studies. It is achieved by observing, 
recording, and analyzing the thermal response at the material surface to a heat stimulus.  
In this study, the one dimensional Green’s function in frequency domain for a 
semi-infinite solid with a plane heat source at the position 0x x= is given as follows [10]: 
0 0( )| | ( )( )
0 0
1( | , ) ( )
2 2
q x x q x xiG x x x x e eω ωω
αω
− − − +−− + = +    (4.1) 
Where the use of “+” signifies that the function satisfies the homogeneous 
Neumann boundary condition at the irradiated sample surface 0x = , which is: 
0




∇ =         (4.2) 
The solution for the temperature ( , )T x ω as a function of depth ( x ) and angular 
modulation frequency (ω ) is then given by [11]:       
0
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Where 0( , )Q x ω is the spectral component of the laser-induced volumetric heat 
source. 
In Eq. (4.1), ( )q ω is a PTW vector defined by: 
( ) (1 ) (1 )
2
fq i iω πω
α α
= + = +       (4.4) 
Where 0.127 α = mm2/s is the thermal diffusivity of aortic tissue and f is 
modulation frequency. From Eq. (4.4), a thermal diffusion length ( µ ), which is a 




=          (4.5) 
Because most of the nanoroses (taken up by macrophages) in atherosclerotic 
plaque are distributed within the intimal layer of artery in rabbit [12], which is several 
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hundred micrometers from the internal arterial wall [13], the modulation 
frequency 4f = Hz is calculated by Eq. (4.5) and used in this study.  
Figure 4.2 shows a schematic of the measurement setup used in this study. Two 
lens coupled fiber optic lasers (Opto Power, Inc., Model FCTS/B; Candela, Model 1200-
001) at the wavelengths of 800 nm and 1210 nm respectively with maximum output 
powers of 5 W were used to irradiate aortic tissues in order to derive information on 
reflected PTW magnitude signals. A 50 mm diameter lens (f = 40 cm) was used to focus 
the collimated laser beam onto a 1.5 cm diameter laser spot on the tissue surface. A 
digital shutter controlled by a function generator (not shown in Figure 4.2) shuttered 
continuous laser light into a frequency of 4 Hz with 50% laser cycle. The IR signal 
(radiometric temperature) from the tissue surface was reflected by a dichroic and then 
recorded by an infrared camera (FLIR Thermal Infrared Camera Systems, Inc.; Model: 
ThermoVision SC6000 with an InSb detector (3.0-5.0 µm)). The shutter and thermal 
camera were synchronized by a photodiode connected with a function generator (not 
shown in Figure 4.2). The extraction of various frequency components present was 




Figure 4.2. Schematic diagram of PTW imaging instrumentation to measure the IR 
signal of the aortic tissue in response to periodic laser irradiation (800 nm and 1210 nm 
respectively). 
4.1.4 Results 
An abdominal artery segment with atherosclerotic plaque was irradiated by 800 
nm and 1210 nm lasers respectively at a frequency of 4 Hz to generate PTWs. The 
radiometric temperature at the tissue surface was recorded by the IR camera over a 10 
second time period at the frame rate of 25.6 Hz. Extraction of images (256 × 256 pixels) 
at various frequencies was performed by Fourier transform at each pixel. Frequency 
amplitude images were obtained corresponding to 800 nm and 1210 nm laser irradiation 
(Figure 4.3) respectively. Computed images suggest that the distributions of nanorose can 
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be identified in amplitude images at 800 nm (Figure 4.3a) and, shapes of plaque lesions 
and fatty streaks (lipid deposits) are shown at 1210 nm (Figure 4.3b). 
 
Figure 4.3. (a) Amplitude image at 800 nm laser irradiation (arrows point to the 
positions of nanoroses). (b) Amplitude image at 1210 nm laser irradiation (arrows point 
to the positions of lipid deposits). 
Overlay of 800 nm and 1210 nm amplitude images shows the relative distribution 
of nanorose and lipids (Figure 4.4a). Red spots in Figure 4.4a show the locations of 
nanorose taken up by macrophages. Dense accumulation of nanorose in a lipid deposit 
region is identified. Nanorose locations correspond to the edges of lipid deposits. 
However, nanorose is not localized at all lipid boundaries (Figure 4.4a) but located at 
some “specialized” locations such as 3C, 4C, 5C, 2D, 5D, 8F, 2G and 5G regions in 
Figure 4.4a. The region of 3C in the frequency amplitude image at 800 nm laser 
irradiation (Figure 4.3a) shows dense accumulation of nanoroses, which is consistent 




Figure 4.4. (a) Overlay of 800 nm and 1210 nm amplitude images (red color indicates 
nanorose, yellow line indicates the edges of lipid deposits). (b) Histology image of RAM-
11 stain along the blue line at the region of 3C in (a). Brown color indicates macrophages 
(arrows point to accumulation positions of macrophages). 
4.1.5 Discussion 
In PTW imaging a common technique to generate thermal waves is through 
absorption of sinusoidal incident intensity modulated light. Unlike the case of sinusoidal 
intensity modulated heating of the sample, a square wave intensity modulated light is 
used in this study. The advantages of square wave signal over the conventional sinusoidal 
signal can be explained by comparing their spectra. While a simple sine wave has only 
one spectral component at a frequency ( / 2 )f ω π= , a square wave can be represented by 
its infinite Fourier series, 
0
4 1( ) sin(2 1)
2 1square b







+∑         
(4.6) 
Computing mean square values of sine and square waves, clear that the energy of 
a square wave is two times higher than the energy of the sine wave of the same 
amplitude. In a square wave the additional energy is due to higher harmonics. More 
energy is injected comparably at the fundamental frequency 0b = in Eq. (4.6), which has 
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an amplitude 1.273 (=4/π) times higher than the sine signal, leading to increased 
amplitude of reflected signal. 
Based on the theory that macrophages are often distributed at sites of plaque 
lesions [14], it is expected that macrophages are located at all edges of lipid deposits of 
the plaque. However, no nanorose is detected at regions such as 4G, 8E and 10F, etc. 
Possible reasons are: (1) Blood flow may influence the distribution of nanorose around 
macrophages. In other words, some macrophages at edgesproprop of lipid deposits may 
not take up nanorose because of local blood flow variation. (2) PTW imaging at 800 nm 
may not show the presence of some nanorose. Because the thermal diffusion length (µ) in 
this study is 100 µm in depth (corresponding to the modulation frequency of 4 Hz), if 
nanorose is located deeper than 100 µm, it is possible that IR camera may not detect the 
radiometric temperature increase at tissue surface due to thermal diffusion. (3) Not all 
macrophages take up nanorose. Nanorose is taken up by macrophages through 
endocytosis. However, if macrophages are not in an “activated” state, which is 
characterized by increased endocytic and phagocytic capacity, anti-inflammatory 
properties and the ability to remodel extracellular matrix [15], endocytosis of nanorose 
may not proceed. 
4.1.6 Conclusion 
Frequency amplitude images corresponding to 800 nm and 1210 nm laser 
irradiation suggest that the distributions of both nanorose and lipid can be identified by 
PTW imaging at a frequency of 4 Hz. Nanoroses taken up by macrophages are distributed 
at the edges of lipid deposits. Observation of high concentration of nanoroses in 
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4.2  MULTI-FREQUENCY PTW IMAGING OF LIPID DEPOSITS IN EX VIVO TISSUES 
4.2.1 Summary 
Atherosclerosis in combination with rupture of vulnerable plaques is the leading 
cause of deaths worldwide, surpassing both infectious diseases and cancer. 
Atherosclerotic plaques are characterized by a thin fibrous cap and a thrombogenic lipid 
core. PTW imaging is based on the periodic thermal modulation of a sample using 
intensity modulated light that is absorbed by target chromophores (lipid in this study) 
generating  a periodic thermal modulation. We report use of PTW imaging to visualize 
three-dimensional distribution of lipid in atherosclerotic plaque in ex vivo atherosclerotic 
tissues taken from a rabbit model of atherosclerosis. The 1210 nm excitation wavelength 
was selected to target lipid. The atherosclerotic plaque sample was irradiated at 
modulation frequencies ranging from 0.1 to 5 Hz to generate PTWs. The radiometric 
temperature at the sample surface was recorded by an infrared (IR) camera over a 20 
second time period at the frame rate of 25.6 Hz. Amplitude and phase images (256×256 
pixels) at selected frequencies were obtained by computing a fast Fourier transform of the 
time-dependent radiometric emission at each pixel. Amplitude and phase images obtained 
at each modulation frequency were related to lateral and depth distribution of lipid in the 
atherosclerotic tissue samples. PTW images recorded from the atherosclerotic plaque 
suggest that lateral and depth distribution of lipid can be identified by analysis of 
amplitude and phase images at selected modulation frequencies. The geometric shape of 
atherosclerotic plaque is associated with distribution of the lipid deposits.  
4.2.2 Descr iption of Design Objective 
Atherosclerosis and specifically rupture of vulnerable plaques leading to 
myocardial infarction, stroke and progression of peripheral artery disease remain the 
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leading cause of death worldwide [1]. Vulnerable plaques are characterized as having a 
thin fibrous cap of less than 65 μm, increased infiltration of macrophages with decreased 
smooth muscle cells, and an increased lipid core size when compared to stable plaques 
[2]. PTW imaging is based on the periodic thermal modulation of a sample using 
intensity modulated light. Intensity modulated light enters the sample and is absorbed by 
targeted chromophores and generates a periodic thermal modulation [3]. The objective of 
this study is to use PTW imaging to visualize the lateral and depth distribution of lipid 
deposits in atherosclerotic plaques in a rabbit animal model of atherosclerosis. Moreover, 
the relationship between distribution of lipid deposits and shape of atherosclerotic plaque 
is discussed. 
4.2.3 Analysis and Performance Evaluation 
A double-balloon injury procedure was performed at the bifurcation of the 
common iliacs on a New Zealand white rabbit. The rabbit was fed with a high fat diet for 
two weeks after balloon injury to induce growth of atherosclerotic lesions. The rabbit was 
then sacrificed, and aorta (Figure 4.5a, b) was harvested and cut into 8×8 mm2 tissue 
segments for PTW imaging.  
Figure 1c shows a schematic of the measurement setup used in this study. A lens 
coupled fiber optic diode laser (Candela, Model 1200-001) at the wavelength of 1210 nm 
with maximum output power of 5 W was used to irradiate aortic tissues. A 50 mm 
diameter lens (f = 40 cm) was used to focus the collimated laser beam onto a 1 cm 
diameter laser spot on the tissue surface. A mechanical shutter controlled by a function 
generator (not shown in Figure 4.5c) shuttered continuous laser light into different 
modulation frequencies ranging from 0.1 to 5 Hz. Infrared radiation from the tissue 
surface was reflected by a dichroic and then recorded by an infrared camera (FLIR 
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Thermal Infrared Camera Systems, Inc.; Model: ThermoVision SC6000 with an InSb 
detector (3.0-5.0 µm)). 
 
Figure 4.5. (a) Sample of atherosclerotic aorta of a Zealand white rabbit. (b) 
Reconstructed OCT image of the same atherosclerotic tissue in Figure 2. Arrow points to 
the plaque. (c) Schematic diagram of PTW imaging instrumentation to measure the IR 
signal of the aortic tissue in response to frequency modulated laser irradiation. 
The radiometric temperature at the tissue surface was recorded by the IR camera 
over a 20 second time period at the frame rate of 25.6 Hz. Extraction of images (256 × 
256 pixels) at various frequencies was performed by fast Fourier transform (FFT) at each 
pixel of the thermal image sequence. Frequency specific amplitude and phase images 
were obtained corresponding to 1210 nm laser irradiation (Figure 4.6).  
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Figure 4.6. (a), (b), (c) FFT amplitude images of a segment of atherosclerotic tissue at 
modulation frequencies of 0.1, 1 and 5 Hz respectively. (d), (e), (f) FFT phase images of 
the same tissue at modulation frequencies of 0.1, 1 and 5 Hz respectively. Scale bar is 5 
mm. 
In both FFT amplitude and phase images (Figure 4.6), lateral distribution of lipid 
deposits can be identified at plaque locations. Because lower frequencies correspond to 
deeper thermal wave penetration depth while higher frequencies correspond to more 
superficial thermal wave penetration depth [4], depth distribution of lipid deposits is 
evident in both amplitude and phase images. 
4.2.4 Discussion 
In PTW imaging a common technique to generate thermal waves is through fixed 
modulation frequency of laser irradiation. Unlike previous studies using a fixed 
modulation frequency, a swept modulation frequency is used in this study. The advantage 
of a swept frequency source over the conventional fixed frequency is understood 
considering the thermal wave penetration depth ( 1/ 20( / )DL D fπ= , where DL , D and 0f are, 
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respectively, penetration depth, thermal diffusivity and modulation frequency). While a 
fixed modulation frequency is targeted to one penetration depth, each frequency 
component in swept modulation frequency corresponds to a different penetration depth 
allowing interrogation of the depth distribution of lipid deposits. 
4.2.5 Conclusion 
Both FFT amplitude and phase images corresponding to 1210 nm laser irradiation 
suggest that lateral and depth distribution of lipid deposits in atherosclerotic plaque can 
be identified by PTW imaging at selected modulation frequencies. The shape of 
atherosclerotic plaque is associated with the distribution of lipid deposits. 
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4.3  SWEPT-FREQUENCY PTW IMAGING OF NANOROSE IN TISSUE PHANTOMS  
4.3.1 Abstract 
We report use of swept-frequency PTW imaging to visualize three-dimensional 
distribution of nanorose in a phantom mimicking atherosclerotic tissue. The excitation 
wavelength of 800 nm was selected to target nanorose. The tissue phantoms were 
irradiated at modulation frequencies ranging from 0.04 Hz to 5 Hz to generate PTWs. 
The radiometric temperature at phantom surface was recorded by an infrared (IR) camera 
over a 20 second time period at the frame rate of 12.8 Hz. Extraction of amplitude and 
phase images (256×256 pixels) at selected frequencies was performed by computing a 
Fourier transform of the time-dependent radiometric emission at each pixel. Amplitude 
and phase images were obtained at each modulation frequency and related to depth of 
nanorose in the phantoms. PTW images recorded from the tissue phantom suggest that 
three-dimensional distribution of nanorose can be identified by analysis of amplitude and 
phase images at selected modulation frequencies.  
4.3.2 Introduction 
Atherosclerosis in combination with rupture of vulnerable plaques is the leading 
cause of deaths worldwide, surpassing both infectious diseases and cancer. In 
atherosclerosis, macrophages infiltrate plaques which are characterized by a thin fibrous 
cap and a lipid core. PTW imaging is based on the periodic thermal modulation of a 
sample using intensity modulated light. The intensity modulated light is absorbed by 
target chromophores (nanorose in this study) and generates a periodic thermal 
modulation. 
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4.3.3 Mater ials and Methods 
In this study, a series of polydimethylsiloxane (PDMS) tissue phantoms were 
prepared in a two-layered geometry (top-layer and substrate) with different top-layer 
thicknesses simulating nanoroses imbedded at different depths of the arterial tissue 
(Figure 4.7). The top-layer (d = 130, 450, 930 um) is composed of PDMS and TiO2, 
while the substrate (10 mm) is composed of PDMS, TiO2  and “UT” letters written by a 
laser beam on surface of substrate and filled with nanoroses at a concentration of 
5×1010/cm3. The top-layers were produced by pouring a PDMS solution onto a 
microscope slide with two identical spacers positioned near the ends of the slide. A 
second microscope slide was placed on top of the PDMS solution and gently pressed 
against the spacers. When polymerization was complete after 24 hours, the top slide was 
carefully removed, exposing a layer of uniform thickness. 
 
Figure 4.7. Side view (a) and cross-section view (b) of PDMS tissue phantoms. The 
two-layered geometry consists of top-layer (①), nanoroses (②) and substrate (③).  
PTW imaging at fixed frequencies is capable of showing chromophores at 
different depths. However, the standard approach requires the same amount of recording 
time for each fixed frequency (i.e., 0.1, 1, 4 Hz). To reduce the recording time, swept 
laser modulation frequencies were used. A mechanical shutter controlled by a function 
generator modulated continuous laser light into swept-frequencies (i.e., 0.04-5 Hz). The 
radiometric temperature at phantom surface was recorded by an infrared (IR) camera over 
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a 20 second time period at the frame rate of 12.8 Hz. Extraction of amplitude and phase 
images (256×256 pixels) at selected frequencies was performed by computing a Fourier 
transform of the time-dependent radiometric emission at each pixel. 
4.3.4 Results 
Figure 4.8 shows the pixel temperature response (Ts) at nanorose location in 
response to swept-frequency laser modulation irradiation (i.e., 0.04-5 Hz) in PDMS tissue 
phantom. A third order (k = 3) polynomial fit (background) was subtracted from the 
original temperature response to eliminate lateral heat diffusion, giving much sharper 
edges at nanorose locations in the tissue phantoms as shown in Figure 4.9.  
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Figure 4.8. Pixel temperature response at nanorose location in response to swept-
frequency laser modulation irradiation (800 nm). 
 
Figure 4.9. Reconstructed three-dimensional amplitude PTW images of nanoroses 
located at a 130 µm depth in PDMS tissue phantom before (a) and after (c) background 
subtraction; Reconstructed three-dimensional phase PTW images of nanoroses located at 
130 µm depth before (b) and after (d) background subtraction. 
Swept-frequency PTW images after background subtraction are shown in Figure 
4.10, representing nanoroses at different depths in PDMS tissue phantoms. Each sub-
figure in Figure 4.10 is a three-dimensional image reconstructed from a stack of 
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amplitude PTW image slices. Each image slice from top to the bottom surface represents 
respectively swept laser modulation frequencies from 5 to 0.04 Hz. “UT” letters 
composed of nanoroses are located at depths of 130 µm (Figure 4.10a), 450 µm (Figure 
4.10b) and 930 µm (Figure 4.10c) respectively. Results show that “UT” letters can be 
clearly seen from the top to the bottom image slices when nanoroses are located at a 130 
µm depth. However, as nanoroses are located deeper in PDMS tissue phantoms, in other 
words, the top-layer thicknesses of the phantoms increase from 450 to 930 µm, “UT” 
letters are not observed in top image slices (Figure 4.10b, c). This phenomenon is due to 
different thermal diffusion lengths at different laser modulation frequencies. Thermal 
diffusion length is a measure of depth probed by PTWs within the sample defined 
by /D mfµ α π= , where µD, α and fm are respectively thermal diffusion length, thermal 
diffusivity and laser modulation frequency. When nanoroses are located deeper, only 
PTWs at lower laser modulation frequencies (i.e., <5 Hz) can reach the depth of 
nanoroses and show contrast in amplitude PTW images. 
 
Figure 4.10. Reconstructed three-dimensional amplitude PTW images with nanoroses 
embedded in PDMS tissue phantoms at depths of (a) 130 µm, (b) 450 µm and (c) 930 
µm. 
The edge of “UT” letters appear sharper when nanoroses are located at a 130 µm 
depth (Figure 4.10a) while more blurred edges are observed when nanoroses are located 
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deeper at 450 and 930 µm depths (Figure 4.10b, c). The result demonstrates that 
chromophore depth and thermal diffusion length µD define PTW amplitude response. For 
laser modulation frequency fm = 0.5 Hz and thermal diffusivity α = 0.104 mm2/s for 
PDMS, the thermal diffusion length µD = 257 µm. Amplitude response of superficial 
chromophores (d = 130 µm < µD) has sharp edges. In the amplitude response of deeper 
chromophores (d = 450, 930 µm > µD), more blurred edges are observed. Though lower 
modulation frequencies (i.e., fm < 0.5 Hz) correspond to longer thermal diffusion lengths 
and thus are able to generate PTWs that can reach deeper chromophores (i.e., d = 450 and 
930 µm), a longer thermal diffusion time is needed for PTWs to reach surface of the 
tissue phantom and detected by the infrared camera. As a result, more heat is laterally 
diffused into the surrounding media and “UT” letters appear more blurred.  
4.3.5 Discussion 
Although background subtraction provides much sharper edges at nanorose 
locations in the tissue phantoms as shown in Figure 4.9, this procedure may modify the 
phase response because subtracting the polynomial fit from the original temperature 
response can introduce a phase artifact. Moreover, as chromophore depth is dependent on 
relative phase change to the surface ( /D DLθ µ∆ = , where Δθ, LD and µD are respectively 
phase change, chromophore depth and thermal diffusion length), this background 
subtraction procedure will result in inaccurate calculation of chromophore depth. 
Therefore, a new background subtraction algorithm is needed to eliminate lateral heat 
diffusion, in the mean while, preserving the phase response. Specifically, a step 
temperature response (Tc) at the same location from continuous laser irradiation will be 
recorded (laser power is the mean power of swept-frequency laser modulation 
irradiation). The subtraction of Tc from Ts will preserve the phase information. 
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The three-dimensional reconstruction algorithm employed in this study is a direct 
reconstruction from a stack of PTW amplitude/phase image slices from high to low 
frequencies (i.e., 5-0.04 Hz). However, because each slice contains chromophore 
information from slices above (higher frequencies than the current slice), a “layer 
stripping” algorithm [1] may need to be applied to eliminate the affect from overlying 
slices. 
4.3.6 Conclusion 
Swept-frequency PTW imaging is capable to detect nanoroses at different depths. 
However, when nanoroses are located deeper, blurred edges of chromophores are 
expected to appear. Based on the results from PDMS tissue phantoms simulating 
nanoroses imbedded at different depths of the arterial tissue, swept-frequency PTW 
imaging is able to detect nanoroses as deep as 930 µm. 
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Chapter  5 Fluorescence Imaging of Macrophages in Atherosclerotic 
Plaques Using Gold Nanopar ticles3
5.1  ABSTRACT 
 
Macrophages are one of the most important cell types involved in the progression 
of atherosclerosis which can lead to myocardial infarction. To detect macrophages in 
atherosclerotic plaques, plasmonic gold nanorose is introduced as a nontoxic contrast 
agent for fluorescence imaging. We report macrophage cell culture and ex vivo tissue 
studies to visualize macrophages targeted by nanorose using scanning confocal 
microscopy. Atherosclerotic lesions were created in the aorta of a New Zealand white 
rabbit model subjected to a high cholesterol diet and double balloon injury. The rabbit 
was injected with nanoroses coated with dextran. A HeNe laser at 633 nm was used as an 
excitation light source and a acousto-optical beam splitter was utilized to collect 
fluorescence emission in 650-760 nm spectral range. Results of scanning confocal 
microscopy of macrophage cell culture and ex vivo tissue showed that nanoroses produce 
a strong fluorescence signal. The presence of nanorose in ex vivo tissue was further 
confirmed by photothermal wave imaging. These results suggest that scanning confocal 
microscopy can identify the presence and location of nanorose-loaded macrophages in 
atherosclerotic plaques. 
5.2  INTRODUCTION 
Atherosclerosis is the major pathologic cause of cardiovascular disease (CVD), 
which is the number one cause of death in the United States - more than any other disease 
including cancer [1]. From 1900 to 2006, deaths caused by CVD increased dramatically 
                                                 




from less than 50,000 to more than 800,000 in the United States [2]. Postmortem studies 
have revealed that myocardial infarction induced by CVD results from an acute process 
of plaque rupture or fissuring of modestly stenotic plaques [3-4]. These atherosclerotic 
plaques are characterized by a thin fibrous cap (< 65 µm), a large lipid core and increased 
macrophage infiltration [5]. Macrophages, originating from monocytes circulating in the 
blood, are trapped and adhered by the inflammatory endothelial cells in the vessel wall. 
The activated macrophages infiltrate into the intimal layer of the arterial wall and are 
capable of degrading the extracellular matrix by secreting matrix metalloproteinases 
(MMPs) or by reducing collagen synthesis and enhancing smooth muscle cell apoptosis 
that may weaken the fibrous cap, making it more prone to rupture [6-8]. Clearly, 
macrophages are one of the key components involved in the pathology and progression of 
atherosclerosis. The majority of current clinical imaging techniques, including X-ray, 
computed tomography (CT), coronary angiography, intravascular ultrasound (IVUS) and 
intravascular optical coherence tomography (IVOCT), focus on detection of 
morphological alterations of the arterial wall that affect the lumen diameter. However, the 
assessment of plaque morphology does not provide direct information on staging of 
atherosclerosis progression and plaque vulnerability. Therefore, molecular imaging 
techniques such as fluorescence microscopy are being investigated for targeting 
macrophages in atherosclerotic plaques by using nanoparticles (NPs) as an imaging 
contrast agent. Scanning confocal microscopy (SCM) is a widely utilized fluorescence 
microscopy technique for “optical sectioning” of tissue at high resolution [9-10]. When 
operated in reflectance mode with high incident excitation laser power density, SCM can 
be used to distinguish cellular components of tissues enhanced by fluorescence dyes. 
Plasmonic gold nanorose (NR) used to target macrophages in this study is a spectrally-
tunable optical nanoaggregate. The 30 nm diameter NR is formed by kinetically 
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controlled assembly of thin gold-shell coated iron oxide nanoparticles in aqueous 
medium [11]. Intense NIR (650-800 nm) absorbance is achieved by the asymmetric core-
shell geometry and collective plasmonic effects from close spacing between primary 
particles in the clusters (Figure 5.1a). A dextran coating on NRs enhances macrophage 
endocytosis and hence macrophages are selectively targeted by NRs. At 633 nm 
excitation, emission fluorescence spectrum of NR-loaded macrophages is characterized 
by two fluorescence peaks (650-670 nm and 740-760 nm) in 650-760 nm spectral range 
(Figure 5.1b). Therefore, NR-loaded macrophages in atherosclerotic plaques are able to 
provide contrast in 650-760 nm spectral range as a fluorescence contrast agent in SCM.  
 
Figure 5.1. (a) Absorbance spectrum of NR colloidal suspension. Inset shows a SEM 
image of one NR cluster with scale bar. (b) Normalized emission spectrum with scale bar 
of NR-loaded macrophages at 633 nm excitation. 
In this study, we investigated the possibility of using gold NRs as a fluorescence 
contrast agent for SCM in macrophage cell culture. Macrophage cell culture was chosen 
to simulate the intimal layer of the atherosclerotic artery since it is well-known that high 
concentration of macrophages in the arterial intima is a characteristic of atherosclerotic 
plaques. To further demonstrate that SCM with NRs as a fluorescence contrast agent can 
be used for imaging superficial macrophages in atherosclerotic plaques, ex vivo tissue 
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experiments were performed on the aortas of a rabbit model of atherosclerosis. Finally, ex 
vivo imaging results from SCM were compared with photothermal wave (PTW) imaging 
of the same tissue samples to confirm the presence of NRs. 
5.3  MATERIALS AND METHODS 
5.3.1 Preparation of Macrophage Cell Culture and Ex Vivo Arter ial Tissues 
To determine NR uptake by macrophages, mouse peritoneal macrophages 
characterized by a high uptake rate were used in this study. Macrophage cells were 
cultivated in DMEM supplemented with 5% FBS at 37 °C in 5% CO2. To load cells with 
NRs, macrophages were incubated with NR suspension (~3×109 NRs/ml) in phenol red 
free and serum free DMEM overnight. NR-loaded macrophages and control macrophages 
without NR were imaged by SCM.  
A double-balloon injury procedure was performed at the bifurcation of the 
common iliacs on a New Zealand white rabbit. The rabbit was fed a high fat diet for six 
weeks after balloon injury to induce atherosclerotic lesions. The rabbit was then 
sacrificed three days after marginal ear vein injection with NRs (1.4 mg NR/kg rabbit 
body weight). The aorta was harvested and flushed with saline to clear the tissue of red 
blood cells. The aorta was cut into several tissue samples (~8×8 mm2) and placed in a 
specimen container with saline before imaging. Arterial tissues with NRs and control 
tissues without NR were imaged by SCM and PTW. All the procedure was performed 
using sterile equipment, supplies and aseptic technique. The animal protocol was 
approved by IACUC at the University of Texas Health Science Center at San Antonio. 
5.3.2 Imaging Systems 
Fluorescence studies of macrophage cell culture (NR-loaded macrophages and 
control macrophages without NR) and ex vivo arterial tissue (a rabbit with NR injection 
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and a control rabbit without NR injection) were performed using a scanning confocal 
microscope (SP2 AOBS, Leica) at the University of Texas at Austin (Figure 5.2a). A 
single mode HeNe laser (633 nm, 15 mW) was used as an excitation light source. A 10× 
objective (0.4NA, WD 2200 µm) and an oil immersion 63× objective (1.4NA, WD 100 
µm) were used for focusing laser light onto samples and collecting fluorescence 
emission. The fluorescence emission was spectrally filtered by an acousto-optical beam 
splitter (650-760 nm), focused onto a 75 µm pinhole for spatial filtering to reject out-of-
focus signals and then reached a PMT (R6357, Hamamatsu).  
To compare and verify the SCM results, PTW imaging was performed using a 
custom-built PTW imaging system (Figure 5.2b). A lens coupled fiber optic laser 
(FCTS/B, Opto Power) at a wavelength of 800 nm with maximum output power of 5 W 
was used to irradiate arterial tissues to induce photothermal waves. A mechanical shutter 
controlled by a function generator intensity-modulated continuous laser light at a 
frequency of 4 Hz. The IR signal (radiometric temperature) emitted from tissue surface 
was reflected by a dichroic mirror and recorded by an IR camera (SC6000, FLIR) at an 
acquisition frame rate of 25.6 Hz. The extraction of amplitude PTW images (256 × 256 
pixels) at various frequencies was performed by computing a fast Fourier transform 
(FFT) at each pixel of the recorded temporal IR image sequence. 
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Figure 5.2. Schematic diagrams of (a) SCM (adapted from [12]) and (b) PTW 
imaging (adapted from [13]). 
5.4  RESULTS 
5.4.1 Fluorescence of NRs in Macrophage Cell Culture 
Differential interference contrast (DIC) images of NR-loaded macrophages and 
control macrophages without NR are recorded using a 63× objective in SCM and shown 
respectively in Figure 5.3a, d. DIC images of macrophage cells clearly demonstrate the 
structures of cell membrane and nuclei. NRs are accumulated and identified as a black 
color inside and outside the macrophage (Figure 5.3a). High accumulation of NRs in 
macrophages suggests that macrophage endocytosis process may be enhanced due to 
dextran coating on NRs. Fluorescence images recorded in 650-760 nm spectral range 
collected by SCM are shown in Figure 5.3b, e. Strong fluorescence signals are observed 
in the NR-loaded macrophage (Figure 5.3b) but not in the control macrophage without 
NR (Figure 5.3e). After image processing, fluorescence images, overlaid in co-registered 
DIC images (Figure 5.3c, f), identify the location of NRs in the macrophage and confirm 
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that fluorescence signals are generated from NRs (Figure 5.3c) and not other cell 
components (Figure 5.3f). Therefore, NR can be used as a fluorescence contrast agent in 
SCM for targeting macrophages. 
 
Figure 5.3. (a, d) DIC images, (b, e) fluorescence images (650-760 nm) and (c, f) 
overlay images of macrophage cell culture with and without NRs. Scale bar is 10 µm. 
5.4.2 Fluorescence of NRs in Ar ter ial Tissues 
To further demonstrate that SCM with NRs as a fluorescence contrast agent can 
be used for imaging macrophages in atherosclerotic plaques, ex vivo tissue experiments 
were performed on a NR injected rabbit and a control rabbit without NR injection. Ex 
vivo arterial tissue samples were imaged by SCM using a 10× objective, transmission and 
fluorescence images are shown in Figure 5.4. Strong fluorescence signals in the tissue 
sample (Figure 5.4c corresponding to the red square region in Figure 5.4a) from a NR 
injected rabbit may indicate the locations of NR-loaded macrophages on the surface of 
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atherosclerotic plaque. The distribution of NR-loaded macrophages in the red square 
region in Figure 5.4a can be better visualized in a 3-D view (Figure 5.4g). The 3-D image 
was reconstructed from 92 frames of lateral scans from the tissue sample surface with 1 
µm apart between each frame. The deposition of NR-loaded macrophages can be 
observed in all the frames, which may indicate that NR-loaded macrophages are 
diffusively distributed in the superficial layer (intima) of the aorta. In contrast, 
fluorescence signals are not detected in the tissue sample (Figure 5.4f corresponding to 
the red square region in Figure 5.4d) from a control rabbit without NR injection using the 
same laser output and PMT amplification.  
 
Figure 5.4. (a, d) Digital images, (b, e) transmission images and (c, f) fluorescence 
images (650-760 nm) of rabbit arterial tissue samples with and without NRs. (g) 
Reconstructed 3-D fluorescence image of red square region in (a). 
Due to intense absorption in the NIR spectral range compared to other arterial 
tissue components, NR can provide contrast in PTW imaging. Therefore, PTW imaging 
was performed to verify the presence of NRs in the same tissue samples as shown in 
Figure 5.4a, d. Because the thermal diffusion length is dependent on laser modulation 
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frequency ( / fµ α π= , where µ, α, f are respectively thermal diffusion length, thermal 
diffusivity and laser modulation frequency), a higher modulation frequency corresponds 
to shorter thermal diffusion length and hence superficial absorbers. A modulation 
frequency of 4 Hz was utilized to detect superficial NRs. Amplitude PTW images were 
obtained corresponding to 800 nm laser irradiation (Figure 5.4a, b). High intensity 
amplitude signals, as denoted by a higher grey value in Figure 5.5a, are detected from the 
same tissue sample as shown in Figure 5.4a. NRs are diffusively distributed on plaque 
surface. The red square region in Figure 5.5a, co-localized with that in Figure 5.4a, 
suggests high concentration of NRs. In contrast, no grey value contrast is observed in 
Figure 5.5b representing the same tissue sample as shown in Figure 5.4d. The red square 
region in Figure 5.5b, co-localized with that in Figure 5.4d, has similar grey values 
compared with surrounding tissue, suggesting no NR is detected in this region. Figure 
5.5c shows the average radiometric temperature increase of the red square regions in 
Figure 5.5a, b in response to laser irradiation. Temperature increase in NR region (red 
square in Figure 5.5a) after ten second laser irradiation is more than two times higher 
than that in control tissue without NR (red square in Figure 5.5b). Moreover, the 
temperature modulation amplitude of NR region is much larger than that of control tissue 
without NR (Figure 5.5c). Results of PTW imaging confirm that fluorescence signals 
obtained by SCM as shown in Figure 5.4c, g are from NRs.  
Therefore, the ex vivo tissue experiment suggests that SCM is capable to detect 
NR-loaded macrophages in atherosclerotic plaques. 
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Figure 5.5. (a) Amplitude PTW image of the tissue sample as shown in Figure 5.4(a) 
at a laser modulation frequency of 4 Hz. (b) Amplitude PTW image of the tissue sample 
as shown in Figure 5.4(d) at a laser modulation frequency of 4 Hz. Scale bar is 2 mm. (c) 
Average radiometric temperature increases of red square regions in (a, b) in response to 
laser irradiation within first ten seconds.   
5.5  DISCUSSION AND CONCLUSION 
Although high yield delivery of NRs into macrophages in atherosclerotic plaques 
was achieved by conjugating dextran to NRs, other biomarkers such as matrix 
metalloproteinases (MMPs) [14] and stromelysin-3 [15] are also identified at 
atherosclerotic lesions. Therefore, investigation of NRs selectively targeting MMPs and 
stromelysin-3 may provide diagnostic value.  
The fluorescence emission spectrum collected in our study is in the range of 650-
760 nm. This spectral range is chosen because NR has two fluorescence emission peaks 
(650-670 nm and 740-760 nm) in this range in response to 633 nm excitation. The 
fluorescence contrast provided by NR in SCM is due to these two emission peaks. 
However, further studies are needed to investigate fluorescence emission spectra of NR 
in response to NIR (650-800 nm) excitation. Due to stronger absorption in NIR range, 
NR with NIR excitation has the possibility to absorb more strongly than 633 nm 
excitation and fluoresce at longer wavelengths. Therefore, better penetration depth of 
SCM may be achieved and deeper NRs could be detected. 
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In this study, we demonstrated that gold NRs can be used as a fluorescence 
contrast agent for SCM in macrophage cell culture. Results of ex vivo tissue experiments 
showed that SCM is capable of ex vivo detection of NRs that were intravenously injected 
and endocytosed by macrophages in atherosclerotic plaques of rabbit aorta in vivo. In 
addition, results of PTW imaging of the same tissue samples confirms that fluorescence 
signals detected by SCM in ex vivo arterial tissue are from NRs and not other tissue 
components in the aorta. 
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Chapter  6 PTW Imaging Combined with OCT for  Macrophage and 
Lipid Detection in Atherosclerotic Plaques Using Gold Nanopar ticles4
6.1  ABSTRACT 
 
The objective of this study was to assess the ability of combined photothermal 
wave (PTW) imaging and optical coherence tomography (OCT) to detect, and further 
characterize the distribution of macrophages (having taken up plasmonic gold nanorose 
as a contrast agent) and lipid deposits in atherosclerotic plaques. Aortas with 
atherosclerotic plaques were harvested from 9 male New Zealand white rabbits divided 
into nanorose- and saline-injected groups and were imaged by dual-wavelength (800 and 
1210 nm) multi-frequency (0.1, 1 and 4 Hz) PTW imaging in combination with OCT. 
Amplitude PTW images suggest that lateral and depth distribution of nanorose-loaded 
macrophages (confirmed by two-photon luminescence microscopy and RAM-11 stain) 
and lipid deposits can be identified at selected modulation frequencies. Radiometric 
temperature increase and modulation amplitude of superficial nanoroses in response to 4 
Hz laser irradiation (800 nm) were significantly higher than native plaque (P<0.001). 
Amplitude PTW images (4 Hz) were merged into a co-registered OCT image, suggesting 
that superficial nanorose-loaded macrophages are distributed at shoulders on the 
upstream side of atherosclerotic plaques (P<0.01) at edges of lipid deposits. Results 
suggest that combined PTW-OCT imaging can simultaneously reveal plaque structure 
and composition, permitting characterization of nanorose-loaded macrophages and lipid 
deposits in atherosclerotic plaques. 
                                                 
4 Significant portions of this chapter have been previously published in J Biomed Opt 17(3), 03600901-
03600910 (2012). 
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6.2  INTRODUCTION 
Atherosclerosis remains the leading cause of death worldwide [1]. The 
macrophage is an important early cellular marker that provides information relevant to 
the risk of future rupture of atherosclerotic plaques. Macrophage infiltration into the 
intimal layer of plaques accelerates inflammation by releasing matrix metalloproteinases 
(MMPs) which erode the fibrous cap and make the plaques more prone to rupture [2-3]. 
Lipid is another important constituent in the progression of atherosclerosis. After entering 
an activated endothelial layer, low density lipoproteins (LDL) are taken up by 
macrophages which have entered the arterial wall. These LDL-loaded macrophages are 
observed in the lipid core as foam cells in post-mortem vulnerable plaques [4-5]. Since 
the vulnerability of plaques is related to cellular composition as well as anatomical 
structure [6], developing a diagnostic method that can simultaneously reveal both is 
critical to identify vulnerable plaques and would allow the determination of macrophage 
density in longitudinal studies in response to therapies without cutting tissue.  
Optical coherence tomography (OCT) has been demonstrated to visualize 
microstructural features such as fibrous cap and surface structure of atherosclerotic 
plaques with high resolution [7-10]. Although Tearney et al showed a correlation 
between OCT and histological measurements of macrophage density in the center of 
fibrous caps [11], and more recently, Liu et al showed that micro-OCT is capable of 
detecting plaque-based macrophages with higher resolution [12], the specificity of 
OCT/micro-OCT alone to identify macrophages is limited by scattering contrast between 
macrophages, lipids and other plaque components such as crystals of cholesterol esters 
and microcalcifications. Photothermal wave (PTW) imaging is a potential screening tool 
for imaging and distinguishing macrophages and lipid deposits in atherosclerotic plaques. 
PTW imaging is based on absorption of light by targeted chromophores which generate a 
 82 
periodic thermal modulation [13-15]. Differences in optical absorption among tissue 
constituents provide contrast in PTW imaging [16]. Multi-wavelength PTW imaging can 
selectively visualize different chromophores in plaque that absorb at selected laser 
irradiation wavelengths. Multi-frequency PTW imaging can localize chromophores at 
multiple depths due to different thermal diffusion lengths at selected modulation 
frequencies [17]. The combination of PTW imaging and OCT may identify the 
distribution of macrophages and lipid deposits in the context of anatomical plaque 
structure in a single merged PTW-OCT image.   
No endogenous optical absorption contrast exists between macrophages and other 
plaque components. A novel gold nanoparticle called nanorose was developed by our 
group to serve as a macrophage targeting chromophore and has been shown to be taken 
up much more aggressively by macrophages than either aortic smooth muscle cells or 
aortic endothelial cells [18]. The 30 nm diameter nanoroses are formed by kinetically 
controlled assembly of thin gold shell coated iron oxide nanoparticles in aqueous 
medium. Nanoroses were injected intravenously, engulfed by plaque-based macrophages 
or blood-based monocytes due to a dextran coating [19], and utilized as a contrast agent 
for PTW imaging to identify macrophages. Broad near infrared (650-800 nm) absorption 
of nanorose with an absorption cross-section (in solution) of 3.1×10-14 m2 at a wavelength 
of 800 nm is achieved by the asymmetric core-shell geometry and plasmonic effects from 
close spacing between primary particles in the cluster [Figure 6.1(a)]. Nanorose 
specificity is provided since the absorption spectra of lipid and other plaque components 
are known to nadir at 800 nm [20] while nanorose has high absorption at this wavelength. 
Moreover, since fatty acids have a local absorption maxima around 1210 nm while the 
absorption of water is relatively lower and nearly constant in this spectral range [Figure 
6.1(b)] [21-22], lasers that emit at wavelengths of 800 nm and 1210 nm were selected to 
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target nanorose and lipid respectively in PTW imaging. Nanorose concentration of 
~2×1010 particles/ml, approximately equal to that on plaque surfaces in our ex vivo 
animal studies, was measured and corresponding nanorose absorption coefficient 
spectrum is shown [Figure 6.1 (b)].  
 
Figure 6.1. (a) Absorbance spectrum of nanorose colloidal suspension. Inset shows a 
scanning electron microscopy (SEM) image of a single nanorose cluster. (b) Absorption 
coefficient spectra of arterial tissues, lipid, water and nanorose. Nanorose concentration 
was typical of that found inside macrophages on plaque surface, based on surface 
radiometric temperature measurement in response to a pulsed laser irradiation at 800 nm 
[23]. 
In this study, we demonstrate for the first time that combined PTW-OCT imaging 
can identify nanorose-loaded macrophages and lipid deposits in a rabbit atherosclerosis 
model. Presence of nanorose-loaded macrophages was confirmed by co-localization of 
two-photon luminescence (TPL) microscopy of nanorose and RAM-11 stain of 
macrophages in histological sections. Our results suggest that nanorose-loaded 
macrophages are (1) localized at the shoulders on the upstream side of atherosclerotic 
plaques associated with lipid deposits and (2) detected superficially within 20 µm of 
plaque surface. This approach could be used to characterize the distribution of nanorose-
loaded macrophages and lipid deposits in atherosclerotic plaques. 
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6.3  MATERIALS AND METHODS 
6.3.1 Macrophage Cell Culture 
To demonstrate nanorose uptake by macrophages, C57/BLK6 mouse peritoneal 
macrophages were incubated with nanorose suspension. Macrophage cells were 
cultivated in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS), L-glutamine (2 mM), penicillin (50 U/ml) and streptomycin 
(100 µg/ml) at 37°C in 5% CO2. To load cells with nanorose, macrophages were 
incubated with nanorose suspension (approximately 3×109 nanoroses/ml) in phenol red 
free and serum free DMEM overnight. Nanorose-loaded macrophages and control 
macrophages without nanorose were imaged by transmission electron microscopy 
(TEM). 
6.3.2 Preparation of Rabbit Ar ter ial Tissues 
A rabbit animal model of atherosclerosis was used to create macrophage-rich 
atherosclerotic plaques in the aorta [24]. Nine male New Zealand white rabbits were fed a 
0.25% cholesterol chow for six months. Six rabbits (Positive group) were sacrificed three 
days following marginal ear vein injection with nanorose (1.4 mg Au/kg rabbit body 
weight) as done previously [25]. The dose of nanorose injection used in this study is 
comparable to the current FDA approved value of 100 mg for a single injection of gold 
sodium thiomalate (per a 70 kg human body) used in the treatment of rheumatoid arthritis 
[26]. The remaining three rabbits (Control group) were sacrificed three days following 
saline injection. The aortas were harvested, cut open, flushed clean of red blood cells and 
placed in sample containers with saline and stored at 4°C before use. Several plaque 
segments (about 8×8×2 mm3) were harvested from the aortas (44 plaque segments from 
the Positive group and 30 plaque segments from the Control group) and positioned en 
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face onto glass-slide sample holders with the luminal side face-up to be imaged by PTW 
imaging and OCT. Orthogonally oriented tape rulers affixed to sample holders indicated 
coordinate positions of plaque segments so that recorded PTW and OCT images could be 
co-registered. All imaging experiments were completed within 12 hours after animal 
sacrifice. The animal protocol was approved by the University of Texas Health Science 
Center at San Antonio IACUC. 
6.3.3 Imaging Systems 
6.3.3.1 PTW Imaging 
Schematic diagram of a custom-built PTW imaging system used in this study is 
presented in Figure 6.2(a). Two lens coupled fiber optic lasers (FCTS/B, Opto Power; 
1200-001, Candela) that emit at wavelengths of 800 and 1210 nm respectively with 
radiant output power of 0.25 W were used to irradiate plaque segments to induce PTWs. 
A 50 mm diameter lens (f=40 cm) was used to focus the laser beam to a 1 cm diameter 
spot size on the plaque segments. A mechanical shutter controlled by a function generator 
(not shown in Figure 6.3) intensity-modulated continuous laser light at fixed frequencies 
(0.1, 1, and 4 Hz) with a 50% duty cycle. The infrared (IR) signal (radiometric 
temperature) emitted from plaque surface was reflected by a dichroic beam splitter and 
recorded by an IR camera (SC6000 with an InSb detector (3.0-5.0 µm), FLIR) over a 20 
second time period at a frame acquisition rate of 25.6 Hz. The extraction of amplitude 
and phase PTW images (256×320 pixels) at each modulation frequency was performed 




A swept source (SS) laser (HSL-1000, Santec) with center wavelength of 1060 
nm and a bandwidth of 80 nm scanning at a repetition rate of 34 KHz was used in the 
custom-built intensity OCT system [Figure 6.2(b)]. Power at the sample arm was 1.2 
mW. The measured free space axial resolution was 20 µm with a 2.8 mm scan depth. The 
OCT signal was sampled with a linear k-space sampling clock to allow real-time OCT 
image acquisition and display. The linear k-space clock was generated from a portion of 
the source light directed into a Mach-Zehnder interferometer and detected by a balanced 
detector. This clock signal was filtered, frequency-quadrupled and used as the input to the 
external clock port of the ADC card. The laser sweep rate governs the A-scan rate of 34 
kHz and images were acquired at a rate of 68 B-scans per second with 500 A-scans per 
B-scan.  
 
Figure 6.2. Schematic diagrams of (a) PTW imaging instrumentation to measure the 
IR signal from plaques in response to periodic laser irradiation (800 and 1210 nm) and 
(b) intensity OCT system to measure plaque surface structure. SS: swept source. 
6.3.3.3 TPL Microscopy 
Measurements of TPL from nanoroses were performed using the custom-built 
NIR laser scanning multiphoton microscope described in a previous study [27]. As the 
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TPL excitation source, a femtosecond Ti:Sapphire laser (Mira 900, Coherent) with 
excitation wavelength of 800 nm was used. The laser beam entering the microscope was 
modulated by an acousto-optic modulator (AOM: 23080-1, NEOS Technologies). The 
focal volume of the objective lens (20×, NA=0.95, water emersion, Olympus) was 
scanned along the sample in the x-y plane using a pair of galvanometric scanning mirrors 
(6215HB, Cambridge Technology) to produce 2-D images. TPL from plaque segments 
was detected by two photomultiplier tubes (PMT1: H7422P-40, PMT2: H7422P-50, 
Hammamtsu) through a dichroic beam splitter (FF735-Di01, Semrock). TPL emission 
spectra (in response to 800 nm excitation) of plaque components such as collagen, elastin 
fibers, oxidized-LDL, neutral lipid and calcification are well below 650 nm [28-30] while 
nanorose has intensive and broad luminescence emission within the wavelength band of 
650-750 nm, endogenous plaque fluorescence and nanorose luminescence were separated 
by a long-pass filter (E570LP, Chroma Technology) with reflection wavelengths shorter 
than 570 nm and a band-pass filter (HQ700/75m, Chroma Technology) with center 
wavelength of 700 nm. Wavelengths shorter than 570 nm from endogenous plaque 
fluorescence were collected by PMT1. Wavelengths longer than 570 nm from nanorose 
luminescence transmitted through the band-pass filter and were collected by PMT2. The 
average Ti:Sapphire laser power incident at the tissue surface was 20 mW and no 
nanorose damage or photo-bleaching effect was observed during imaging. 
6.3.4 Histology Analysis 
Aorta sections (5 µm in thickness) were immersion-fixed in formalin, processed 
with paraffin embedding and stained with RAM-11 [31], a marker of rabbit macrophage 
cytoplasm. 
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6.3.5 Statistical Analysis 
Statistical analysis was performed using SPSS Software for Windows (Version 
19.0.0, SPSS). Radiometric temperature increase of plaque is given as mean temperature 
increase per excitation pulse over specific regions (nanorose regions in the Positive group 
and plaque regions with no nanorose in the Control group) in each plaque segment using 
PTW imaging. The comparison of superficial nanorose distribution in plaques is given as 
an area percentage of nanorose at plaque shoulders on the upstream versus downstream 
side. A two-tailed independent-sample Student’s t test was performed for comparison of 
mean temperature increase of plaques from Positive and Control groups. The findings of 
nanorose distribution in plaques from the Positive group were compared by applying a 
two-tailed paired-sample Student’s t test. A two-tailed P value less than 0.05 was 
considered statistically significant for both tests. 
6.3.6 Analysis of Area Percentage of Nanorose in Plaques 
Area percentage of nanorose at plaque shoulders on the upstream versus 
downstream side in each plaque segment (N=44) in the Positive group was calculated 
according to the ratio of nanorose pixel number defined by the pixel number of nanorose 
at plaque shoulders on the upstream versus downstream side, respectively, to a total pixel 
number of nanorose in each plaque segment. ImageJ software was used for the 
percentage measurement. Data are presented as mean±SD. 
6.4  RESULTS 
6.4.1 Nanorose Uptake by Macrophages 
After overnight (24 hours) macrophage incubation, nanoroses are observed to 
accumulate in lysosomes inside macrophages [Figure 6.3(a)]. Nanoroses are not localized 
in all lysosomes but appear more frequently in those close to the cell surface. Both single 
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nanorose and nanorose clusters are observed (inset in [Figure 6.3 (a)), suggesting that 
nanoparticle aggregation occurs during macrophage internalization. Dense accumulation 
of nanoroses in lysosomes indicates substantial macrophage endocytosis of 30 nm 
dextran-coated nanorose in cell culture.  
 
Figure 6.3. TEM images of (a) peritoneal macrophages loaded with nanorose and (b) 
peritoneal macrophages without nanorose. Red arrow points to a lysosome which is 
magnified in a red square at the upper right corner in (a) where single nanorose and 
nanorose clusters are observed. Scale bar is 2 µm.  
6.4.2 Nanorose Identification by TPL Microscopy in Histological Sections 
TPL microscopy was used to identify the presence of nanorose in unstained 
histological sections (5 µm in thickness) excised from plaque segments in the Positive 
group. To demonstrate plaque fluorescence and nanorose luminescence simultaneously, 
TPL images from the two PMTs were recorded separately and merged into a single 
image. Figure 6.4(a) illustrates a TPL image of plaque measured with emission 
wavelengths shorter than 570 nm. Figure 6.4 (b) shows nanorose TPL collected through a 
700 nm band-pass filter. These two images collected in separate emission wavelengths 
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were assigned to different channels (plaque: green channel; nanorose: red channel) and 
merged [Figure 6.4 (c)]. In images presented throughout the remainder of this 
manuscript, endogenous fluorescence from plaque is green while luminescence from 
nanorose is red. 
 
Figure 6.4. Co-registered TPL images of an unstained histological section of plaque 
from the Positive group. (a) TPL images of plaque measured at emission wavelengths 
shorter than 570 nm (green). (b) TPL images of nanoroses measured via a 700 nm band-
pass filter (red). (c) Merged image of (a) and (b). Yellow arrows in (c) point to nanorose 
locations. SP: short-pass (<570 nm); BP: band-pass (700/75 nm). 
6.4.3 PTW Imaging of Superficial Nanoroses and Lipid Deposits in Atherosclerotic 
Plaques 
Plaque segments from Positive and Control groups were irradiated by 800 and 
1210 nm laser radiation at a frequency of 4 Hz to generate PTWs from superficial 
chromophores (nanoroses and lipid deposits that are within 100 µm in depth from plaque 
surface). Amplitude and phase PTW images at a modulation frequency of 4 Hz were 
computed (Figure 6.5). Location of stronger light absorption corresponding to nanoroses 
can be identified in both amplitude and phase PTW images at 800 nm [Figure 6.5(a) and 
(5e)] and, shapes of plaque lesions and lipid deposits are revealed at 1210 nm [Figure 
6.5(b), 5(f), 5(d) and 5(h)]. Phase PTW images not only show locations of nanoroses and 
lipid deposits, but also reveal depth information as the gray scale assigns darker colors to 
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smaller phase values [Figure 6.5(e) and 5(h)]. Because amplitude PTW images have 
better contrast and SNR than phase images, amplitude PTW images were used for further 
image analysis. 
 
Figure 6.5. Amplitude (a,b,c,d) and phase (e,f,g,h) PTW images of atherosclerotic 
plaques from Positive and Control groups respectively at 800 and 1210 nm laser 
irradiation. Laser modulation frequency is 4 Hz. Red arrows point to the position of 
nanoroses in (a) and lipid deposits in (b, d). Red squares indicate regions with and 
without nanorose in (a) and (c), respectively. Scale bar is the same in (a,b,e,f) and 
(c,d,g,h), respectively. 
Radiometric temperature increase in 44 plaque segments from the Positive group 
and 30 plaque segments from the Control group were compared to determine the 
presence of nanorose and to distinguish nanorose from plaque. Figure 6.6(a) shows the 
average radiometric temperature response from red square areas in Figure 6.5(a) and 
6.5(c). The highest radiometric temperature increase and modulation amplitude were 
observed in regions with nanorose aggregation from the Positive group over the first ten 
seconds after laser irradiation. In contrast, a much lower radiometric temperature increase 
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and smaller modulation amplitude were observed in the Control group. Figure 6.6(b) 
shows the comparison of mean radiometric temperature increase per excitation pulse at 
regions with (red) and without (blue) nanorose in all plaque segments from Positive and 
Control groups, respectively. An independent-sample Student’s t test reveals a 
significantly higher mean radiometric temperature increase per excitation pulse at 
nanorose regions in the Positive group compared to the Control group (P<0.001). 
 
Figure 6.6. (a) Average radiometric temperature increase in response to 800 nm laser 
irradiation at a modulation frequency of 4 Hz measured from plaque area containing 
nanorose (bright regions in the red square in Figure 6.5(a)) in the Positive group and area 
with no nanorose (red square in Figure 6.5(c)) in the Control group. (b) Radiometric 
temperature increase per pulse at a laser modulation frequency of 4 Hz from all plaque 
segments in Positive and Control groups, respectively. Data are given as mean±SD. 
Overlay of 800 and 1210 nm amplitude PTW images from Figure 6.5(a) and 6.5(b) 
shows the relative spatial distribution of nanorose and lipid deposits [Figure 6.7(a)]. Red 
regions in Figure 6.7(a) show locations of superficial nanorose aggregates as detected by 
PTW imaging at 800 nm. Detected regions of nanorose correspond to the edges of 
superficial lipid deposits. Nanorose is not present at all lipid edges but at discrete 
locations (e.g., 1B,1C,2A,3B,3C) in Figure 6.7(a). The blue dashed line in region 2A in 
the overlay image [Figure 6.7(a)] shows an accumulation of nanoroses, consistent with 
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the histological section from the same region where a dense accumulation of 
macrophages is identified by RAM-11 stain [Figure 6.7(b)]. In contrast, macrophages are 
not observed [Figure 6.7(c)] in regions with no PTW signals from nanorose (yellow 
dashed line in Figure 6.7(a)). 
Merged TPL images from an unstained histological section adjacent to the section in 
Figure 6.7(b) are shown in Figure 6.7(e)-6.7(g) with increased magnification. Strong TPL 
signals from nanorose are observed (red color pointed by yellow arrows in Figure 6.7(g)). 
Endogenous plaque fluorescence, which may originate from elastin fibers and collagen 
[28,30,32], is also observed in the plaque (green color in Figure 6.7(e)-6.7(j)). Nanoroses 
identified by TPL microscopy co-localize with superficial macrophages [Figure 6.7(g)], 
indicating that PTW signals at 800 nm laser irradiation are generated by nanorose-loaded 
macrophages. The size of nanorose aggregations in macrophages varies from less than 1 
μm to about 10 μm [Figure 6.7(g)], suggesting that the concentration of engulfed 
nanoroses in macrophages is variable. Although macrophages are observed as deep as 
200 μm from the plaque surface [Figure 6.7(b)], nanorose distribution is restricted within 
the first 20 μm [Figure 6.7(g)]. This observation may suggest that the nanorose-loaded 
macrophages mostly reside in the very superficial regions of intima and have not 
migrated to deeper locations up to three days after intravenous nanorose injection. In a 
region of the same plaque segment from the Positive group where no PTW signals from 
nanorose are detected [Figure 6.7(c)], only endogenous plaque fluorescence from elastin 
fibers is observed [Figure 6.7(h)-6.7(j)]. A histological section of plaque from the Control 
group with a dense accumulation of macrophages [Figure 6.7(d)] was also imaged by 
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TPL microscopy [Figure 6.7(k)-6.7(m)]. Fluorescence from elastin fibers is detected. 
Moreover, macrophage-like cellular structures with dark nuclei (indicated by a yellow 
circle) and possibly lipid droplets in or outside macrophages (pointed by yellow arrow 
heads) are observed in Figure 6.7(m) [33-34]. 
 
Figure 6.7. (a) Overlay of amplitude PTW images from Figure 6.5(a) and 5(b). Red 
color indicates nanorose. (b,c) Histological sections of plaque from the Positive group 
with RAM-11 stain along blue and yellow dashed lines in regions 2A and 4B respectively 
in (a). (d) Histological section of plaque from the Control group with RAM-11 stain. 
Brown color in (b) and (d) indicates macrophages. (e,f,g), (h,i,j), (k,l,m) Merged TPL 
images of unstained histological section adjacent to the section in (b), (c) and (d), 
respectively. Red square region in (b), (c) and (d) corresponds to (e), (h) and (k), 
respectively. Yellow square region in (e), (h) and (k) corresponds to (f), (i) and (l), 
respectively. Blue square region in (f), (i) and (l) corresponds to (g), (j) and (m), 
respectively. Inset in (g) shows co-localized RAM-11 stain of (g) magnified from (b). 
Yellow arrows in (g) point to nanorose locations. Yellow arrow heads in (m) point to 
lipid droplets. Yellow circle in (m) indicates clusters of macrophages. 
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6.4.4 Multi-Frequency PTW Imaging in Combination with OCT 
Detection of chromophores located deeper in the tissue using PTW imaging 
requires reduced laser modulation frequencies. Therefore, laser modulation frequencies 
of 0.1 and 1 Hz were applied to visualize deeper nanorose-loaded macrophages and lipid 
deposits (600 and 200 µm thermal diffusion lengths in response to 0.1 and 1 Hz laser 
modulation frequencies, respectively). In Figure 6.8, amplitude PTW images at three 
modulation frequencies are shown. At 800 nm laser irradiation, nanoroses produce the 
strongest PTW signals at 4 Hz [Figure 6.8(c)], much weaker at 1 Hz [Figure 6.8(b)] and 
negligible signal contrast at 0.1 Hz [Figure 6.8(a)], suggesting that nanorose-loaded 
macrophages are primarily superficially distributed in the plaque (i.e., < 100 µm), 
consistent with merged TPL microscopy images (red color in Figure 6.8(i)-6.8(k)).  
At 1210 nm laser irradiation, lipid deposits produce strong PTW signals at all three 
frequencies, denoted by black arrows in Figure 6.8(d)-6.8(f). This observation indicates 
that lipid deposits distribute over multiple depths in the plaque. The bright region where 
the arrow points in Figure 6.8(d) reveals the location of a lipid core in the plaque. 
Amplitude PTW images at lower modulation frequencies [Figure 6.8(a), 6.8(b), 6.8(d) 
and 6.8(e)] appear more blurred than images at higher frequency [Figure 6.8(c) and 
6.8(f)] due to greater lateral heat diffusion in the plaque.  
Amplitude PTW images at a modulation frequency of 4 Hz [Figure 6.8(c) and 6.8(f)] 
were merged into a co-registered OCT image [Figure 6.8(g)]. The merged PTW-OCT 
image shows a topographic surface structure of the plaque. Peak (P) and valley (V) 
regions are observed. The blue dashed line in the merged PTW-OCT image shows an 
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accumulation of nanoroses, consistent with the histological section from the same region 
where a dense accumulation of macrophages is identified [Figure 6.8(h)]. Merged TPL 
images from an unstained histological section adjacent to the section in Figure 6.8(h) are 
shown in Figure 6.8(i)-6.8(k). Strong TPL signals from nanorose are observed within 20 
µm from plaque surface [Figure 6.8(k)] and endogenous plaque fluorescence from elastin 
fibers and lipid droplets is also observed [Figure 6.8(j)]. Interestingly, Figure 6.8(g) 
shows that superficial lipid deposits are surrounded by nanorose-loaded macrophages 
located close to the shoulders of the plaque. The relative distribution of nanorose-loaded 
macrophages to lipid deposits is consistent with that in Figure 6.7(a) and observed 
repeatedly in other plaques (19 of 44 plaque segments (43%) in the Positive group). Of 
note is that the direction of blood flow in the live animal is from top to bottom in the 
image as depicted by red arrows above Figure 6.8(g).  
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Figure 6.8. (a,b,c,d,e,f) Amplitude PTW images of a plaque segment from the Positive 
group at 800 and 1210 nm laser irradiation, respectively. Laser modulation frequencies 
are respectively 0.1, 1 and 4 Hz with corresponding thermal diffusion lengths of 600, 200 
and 100 µm. Black arrows point to lipid deposits in (d), (e) and (f). (g) Co-registered and 
merged PTW-OCT image (Video 1, MPEG, 2.5 MB). Red, yellow, and green colors in 
(g) represent respectively nanorose-loaded macrophages, lipid deposits and both. White 
arrows point to peak (P) and valley (V) regions of the plaque in (g). Red arrows above (g) 
indicate direction of blood flow. (h) Histological section with RAM-11 stain along blue 
dashed line in (g). (i,j,k) Merged TPL images of unstained histological section adjacent to 
the section in (h). (i), (j) and (k) respectively represents red, yellow and blue square 
region in (h), (i) and (j). (l) Area percentage of nanorose at shoulders on the upstream 
versus downstream side of the plaques (N=44) from the Positive group. Larger area 
percentage of nanorose are observed at plaque shoulders on the upstream side (P<0.01). 
Yellow arrows in (k) point to nanorose locations. 
6.5  DISCUSSION 
The presently employed imaging contrast agent, nanorose, represents a novel gold 
nanoparticle that is taken up by macrophages. Many investigators have noted that particle 
size is an important factor in cellular uptake of gold nanoparticles. Chithrani et al 
observed that gold nanoparticle endocytosis by Hela cells is strongly size-dependent with 
higher uptake rates for particle sizes between 30 and 60 nm [35]. Recently, Jiang et al 
showed that the internalization of Herceptin-gold nanoparticles by human breast cancer 
cells was most efficient at 25-50 nm size range [36]. Furthermore, larger nanoparticles 
tend to have a short blood half-life and are quickly removed from circulation by liver and 
spleen [37]. In contrast, smaller nanoparticles have a longer blood residence time giving 
greater chance of being taken up by circulating blood-based monocytes and plaque-based 
macrophages [38]. Therefore, nanorose with a 30 nm particle size and non-ionic dextran 
coating is potentially effective to increase macrophage uptake and decrease opsonization 
and subsequent removal by liver and spleen. In this study, a 3-day interval between 
nanorose injection and PTW-OCT imaging was used to ensure nanorose uptake by 
macrophages. However, this time interval may not be clinically optimal. Interestingly, 
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magnetic susceptibility artifacts (MSAs) induced by the injected ferumoxtran-10 (one 
type of ultrasmall superparamagnetic nanoparticles of iron oxide) have been detected 
optimally in the carotid arteries of patients 24 to 48 hours after the injection while almost 
no signal contrast was observed at 72 hours [39], suggesting that shorter time intervals 
may be considered in future studies. 
In this study, the majority of nanoroses observed were found to be superficial and 
localized at the shoulders of plaques, especially on the upstream side of lesions, 
suggesting that macrophages which had engulfed the nanorose were co-localized at these 
regions. A paired-sample Student’s t test reveals a significantly larger area percentage of 
nanorose at shoulders on the upstream compared to the downstream side (P<0.01) of the 
plaques [Figure 6.8(l)]. This finding is consistent with a previous study by Dirksen et al 
who showed that 67% of the 33 human carotid plaques collected contained more 
macrophages in upstream shoulder regions where higher flow rate and higher shear stress 
prevails [40]. Recently, a review by Slager et al confirmed that macrophages predominate 
on the upstream side of the plaque induced by high shear stress [41]. In fact, increased 
expression of MMPs by macrophages in plaques appears to be restricted to shoulder 
regions of plaques [42-45]. Moreover, rupture of atherosclerotic plaques has been 
reported to occur predominantly at macrophage-rich shoulders of the plaque’s fibrous cap 
[40,46-48]. Therefore, the observation of high density of nanorose, engulfed by 
macrophages, at plaque shoulders on the upstream side in our study demonstrates that a 
combined PTW-OCT imaging approach with nanorose as a contrast agent has predictive 
value for plaque vulnerability.  
Most nanoroses detected by TPL microscopy were superficial, within 20 μm from 
plaque surface. However, RAM-11 stained macrophages were distributed as deep as 200 
μm. This observation suggests that only superficial macrophages in the plaque took up 
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nanorose. Macrophages that already migrate into deeper locations may not be able to take 
up nanorose either because nanorose cannot penetrate deeply into the intima or 
probability of nanorose’s delivery through the vasa vasorum is low or does not occur. 
Moreover, apoptotic and necrotic macrophages contribute to lipid core formation in 
plaques [49], and these macrophage debris could stain RAM-11 positive but are not intact 
and are unable to take up free nanorose in situ. 
Although nanorose uptake by macrophages has been identified in our cell culture 
study (Figure 6.3), their transport pathway to plaque-based macrophages is not clear. 
Previous studies have proposed three mechanisms for transport of superparamagnetic 
nanoparticles to arterial tissue [50-53]: 1) nanoparticles are endocytosed by activated 
blood monocytes which migrate through the lumen into the intimal surface; 2) 
transcytosis of nanoparticles across the endothelium and into the intima followed by 
uptake by in situ macrophages; and 3) diffusion of individual nanoparticles into the 
adventitia via the vasa vasorum. Our PTW imaging (at 0.1 Hz laser modulation) and TPL 
microscopy results of a plaque segment [Figure 6.8(a)] and histological section [Figure 
6.8(i)], respectively, show that nanorose is not detected at deeper plaque locations (e.g., 
100-600 µm), suggesting that nanorose transport via the vasa vasorum may not have 
occurred in our study. Interestingly, TPL images of a histological section of plaque from 
the Positive group show a “snapshot” of a nanorose-loaded monocyte-like cell entering 
the plaque surface (Figure 6.9). Sparsely distributed nanoroses are visible inside the cell. 
This image suggests that nanoroses can be first endocytosed by monocytes in the blood 
stream and then enter the plaques through the lumen. Further study, however, is needed 
to determine the relative contributions of these proposed mechanisms to enhance the 
clinical value of PTW-OCT imaging. 
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Figure 6.9. Co-registered TPL images of a nanorose-loaded monocyte-like cell 
entering the plaque surface from an unstained histological slice of plaque from the 
Positive group. (a) TPL images of plaque measured at emission wavelengths shorter than 
570 nm (green). (b) TPL images of nanoroses measured via a 700 nm band-pass filter 
(red). (c) Merged image of (a) and (b). Yellow arrow in (c) points to nanorose location. 
SP: short-pass (<570 nm); BP: band-pass (700/75 nm). 
We demonstrate for the first time that dual-wavelength multi-frequency PTW 
imaging can be used to detect and distinguish plaque components. With excitation 
wavelengths that match high absorption spectral regions of different chromophores in 
atherosclerotic plaques, PTW imaging provides contrast for nanorose-loaded 
macrophages and lipid deposits. Moreover, axial distribution of nanorose-loaded 
macrophages and lipid deposits can be determined at selected laser modulation 
frequencies, giving additional diagnostic information of atherosclerotic plaques such as 
macrophage infiltration depth and lipid core location. Although OCT shows tomographic 
plaque surface structure and is able to resolve fibrous caps (usually less than 65 μm in 
thickness), this imaging method alone does not provide specificity for macrophages and 
lipid deposits due to lack of scattering contrast among different plaque components. 
Merged tomographic PTW-OCT images can simultaneously reveal plaque composition 
with respect to plaque surface structure, which substantially enhances the capability of 
OCT in the study of characterizing plaque components and allows observation of known 
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biological phenomena (e.g., macrophages distributed at shoulders on the upstream side of 
atherosclerotic plaques). From a clinical perspective, imaging macrophages and lipid 
deposits in the context of plaque surface structure offers the ability to identify plaque 
regions more prone to rupture. Currently, our study utilized ex vivo tissues and the 
clinical translation of combined PTW-OCT imaging would face many implementation 
challenges. Beard et al demonstrated an optical fiber photoacoustic-photothermal probe 
[54] which has the potential to perform intravascular PTW imaging. Recently, 
photothermal OCT systems [25,55-57] have been reported to record optical pathlength 
variation due to thermal-elastic and thermorefractive changes induced by absorption of 
incident radiation. Both candidate approaches require engineering development to 
incorporate into an intravascular catheter. The motivation for future development of 
intravascular PTW imaging in combination with an OCT catheter [58-59] during heart 
catheterization to detect nanorose-loaded macrophages and lipid deposits in plaques in 
vivo appears promising. Intravascular PTW-OCT imaging using nanorose as a contrast 
agent could allow clinical studies that monitor nanorose-loaded macrophages in response 
to various therapeutic interventions in vivo. Such an imaging tool would be of value to 
determine macrophage and lipid density over time rather than the current standard of 
autopsy studies that provide a single time point measurement. 
6.6  CONCLUSION 
By utilizing PTW imaging in response to 800 and 1210 nm laser irradiation we 
demonstrated detection of PTW signals from nanorose and lipid deposits in 
atherosclerotic plaques. Moreover, multi-frequency (0.1, 1 and 4 Hz) PTW imaging can 
be used to distinguish nanorose and lipid deposits distributed at different depths. 
Nanorose presence was also identified with TPL microscopy in histological sections. Co-
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localization of nanorose shown in TPL microscopy with RAM-11 stained macrophages 
suggests that PTW signals at 800 nm laser irradiation is generated by superficial 
nanorose-loaded macrophages. Amplitude PTW images (800 and 1210 nm) at a 
modulation frequency of 4 Hz merged with a co-registered OCT image demonstrated the 
location and distribution of superficial nanorose-loaded macrophages and lipid deposits 
with respect to plaque surface structure and direction of blood flow. Our results suggest 
that nanorose-loaded macrophages are distributed at plaque shoulders on the upstream 
side, at edges of lipid deposits, and superficially located (within 20 μm from plaque 
surface). This ex vivo animal study suggests that combined PTW-OCT imaging is a 
promising imaging approach for multi-depth screening of nanorose-loaded macrophages 
and lipid deposits in atherosclerotic plaques. 
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Chapter  7 Two-photon Luminescence (TPL) Microscopy Combined 
with OCT for  Macrophage Detection in the Hypercholesterolemic 
Rabbit Aor ta Using Gold Nanopar ticles5
7.1  ABSTRACT 
 
The macrophage is an important early cellular marker related to risk of future 
rupture of atherosclerotic plaques. Two-channel two-photon luminescence (TPL) 
microscopy combined with optical coherence tomography (OCT) was used to detect, and 
further characterize the distribution of aorta-based macrophages using plasmonic gold 
nanorose as an imaging contrast agent. Nanorose uptake by macrophages was identified 
by TPL microscopy in macrophage cell culture. Ex vivo aorta segments (8×8×2 mm3) 
rich in macrophages from a rabbit model of aorta inflammation were imaged by TPL 
microscopy in combination with OCT. Aorta histological sections (5 µm in thickness) 
were also imaged by TPL microscopy. Merged two-channel TPL images showed the 
lateral and depth distribution of nanorose-loaded macrophages (confirmed by RAM-11 
stain) and other aorta components (e.g., elastin fiber and lipid droplet), suggesting that 
nanorose-loaded macrophages are diffusively distributed and mostly detected 
superficially within 20 µm from the luminal surface of the aorta. Moreover, OCT images 
depicted detailed surface structure of the diseased aorta. Results suggest that TPL 
microscopy combined with OCT can simultaneously reveal macrophage distribution with 
respect to aorta surface structure, which has the potential to detect vulnerable plaques and 
monitor plaque-based macrophages overtime during cardiovascular interventions. 
                                                 




7.2  INTRODUCTION 
Atherosclerosis and plaque rupture leading to myocardial infarction, stroke and 
progression of peripheral artery disease remain the leading cause of death worldwide, far 
surpassing both infectious diseases and cancer [1]. Many investigators once believed that 
progressive luminal narrowing or stenosis beginning from increased lipid storage and 
continued growth of smooth-muscle cells in the plaque was the main cause of myocardial 
infarction [2]. Angiographic studies have, however, identified that culprit lesions do not 
arise from critical stenosis. Previous work by Ambrose et al, Little et al, Nobuyoshi et al 
and Giroud et al demonstrated that nearly two thirds of myocardial infarctions occur in 
lesions that showed only moderate stenosis [3-8]. Recent advances in basic and 
experimental science have established a fundamental role that inflammation and 
underlying cellular and molecular mechanisms [9-11] contribute to atherogenesis from 
initiation through progression, plaque rupture and ultimately, thrombosis. The principal 
pathologic features of atherosclerotic plaques that are prone to rupture are now well 
described [12]. Accumulations of macrophages in atherosclerotic plaques over-express 
matrix metalloproteinases (MMPs), such as MMP-1 (collagenase-1), MMP-3 
(stromelysin-1), and MMP-9 (gelatinase-B) [13-16].  Over-expression of such matrix-
degrading enzymes is believed to contribute to plaque instability and thrombogenicity 
[17-19]. Thus, the macrophage is an important early cellular marker that indicates and 
contributes to increased risk of plaque remodeling and subsequent rupture in the 
coronary, cerebral, and peripheral circulations. Since plaque instability is related to 
cellular composition as well as anatomical structure, developing a diagnostic method that 
can simultaneously reveal both is critical to identify vulnerable plaques and would allow 
in vivo monitoring of macrophage density in longitudinal studies in response to 
cardiovascular interventions.  
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Currently, x-ray angiography, magnetic resonance imaging (MRI), intravascular 
ultrasound (IVUS), computed tomography (CT), single-photon emission CT (SPECT) 
and positron emission tomography (PET) have been utilized to image atherosclerotic 
cardiovascular diseases (e.g., atherosclerotic plaques in the arterial wall) [20,21]. MRI 
can achieve molecular imaging using contrast agents [22,23]. IVUS can perform virtual 
histology by using spectral analysis to identify plaque components [24,25]. CT and 
PET/CT using contrast agents can image macrophage infiltration into arterial wall with 
improved sensitivity [26,27]. SPECT/CT can track monocytes recruitment to 
atherosclerotic plaques in vivo [28]. However, none of these techniques is able to provide 
cellular or subcellular resolution. Two-photon luminescence (TPL) microscopy uses 
nonlinear optical properties of tissue and has been recently utilized to image plaque 
components such as endothelial cells, smooth muscle cells [29], elastin fibers [30,31], 
oxidized LDL [32] and lipid droplets [33] based on their endogenous autofluorescence. 
Optical coherence tomography (OCT) has been demonstrated to visualize microstructural 
features such as fibrous cap and surface structure of atherosclerotic plaques with high 
resolution [34-37]. Due to poor scattering and weak two-photon absorption contrast 
between macrophages and other plaque components, OCT or TPL microscopy alone, is 
not able to detect macrophages with high specificity while depicting detailed plaque 
structures.  
To solve this problem, a novel gold nanoparticle called nanorose [38] was used as 
an imaging contrast agent for TPL microscopy to target macrophages. The 30 nm 
diameter nanorose is characterized by the assembly of thin gold shell (1-2.5 nm in 
thickness) coated iron oxide (5 nm in diameter) nanoparticles. Dextran-coated nanoroses 
were injected intravenously and engulfed by aorta-based macrophages or blood-based 
monocytes [39]. Broad near infrared (650-800 nm) absorption of nanorose is achieved by 
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the asymmetric core-shell geometry and plasmonic effects arising from close spacing 
between primary particles in the cluster (Figure 7.1A). Nanorose specificity is achieved 
since endogenous fluorescence emission (in response to 800 nm two-photon excitation) 
of collagen, elastin fibers, oxidized-LDL, calcification and lipid are all below 650 nm 
[32,33,40] while TPL emission of nanorose is broad and emission intensity increases 
beyond this wavelength (Figure 7.1B). Two emission channels (<570 nm and 700/75 nm) 
were selected to separate nanorose-loaded macrophages and other aorta components in 
TPL microscopy.  
 
Figure 7.1. A: Absorbance spectrum of nanorose colloidal suspension. Inset shows a 
schematic cartoon (left) and scanning electron microscopy image (right) of a single 
nanorose cluster. B: TPL emission spectra of nanorose in gelatin (red) and gelatin alone 
(blue) at an excitation wavelength of 800 nm. Nanorose suspension (3.3×1011 
nanoroses/ml) was mixed with 8% (wt/wt) gelatin to make a nanorose-gelatin tissue 
phantom (1.99×1011 nanoroses/ml). A shortpass filter (<750 nm) was placed in front of 
the spectrometer detector in order to block the laser line. 
In this study, we demonstrate for the first time that TPL microscopy in 
combination with OCT using nanorose as a contrast agent can identify aorta-based 
macrophages in the context of aorta surface structure in a double-balloon injured 
hypercholesterolemic rabbit model. Presence of nanorose-loaded macrophages was 
confirmed by co-localization of TPL microscopy of nanorose and RAM-11 staining of 
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macrophages in aorta histological sections. This combined imaging approach can 
simultaneously reveal cellular composition and anatomical structure of the aorta and has 
the potential to assess macrophage distribution over time.  
7.3  MATERIALS AND METHODS 
7.3.1 Synthesis of Imaging Contrast Agent (Nanorose) 
Details of nanorose synthesis were described previously [38]. Briefly, iron oxide 
nanoparticles were first synthesized using a method modified from Shen et al [41]. 4 ml 
of NH4OH (>25% wt/wt) was used to titrate 15 ml of a dextran aqueous solution (15% 
wt/wt) to pH 11.7. To this, 5 ml of freshly prepared 0.75 g of FeCl3·6H2O and 0.32 g of 
FeCl2·4H2O aqueous solution was injected dropwise after passing through a hydrophilic 
0.2 μm filter. The suspension immediately turned black and was stirred for 0.5 h. The 
mixture was then centrifuged at 10,000 rpm for 9 min to remove aggregates. The 
supernatant was decanted and dialyzed (Spectra/Pro 7, Spectrum Laboratories) against DI 
water for 24 h. To concentrate dispersions, a centrifugal filter device (Ultracel YM-30, 
Millipore) was used with a relative centrifugal force of 1500 g. To synthesize the gold-
coated iron oxide clusters, 0.1 ml (14.6 mg Fe/ml) of dextran-coated iron oxide 
nanoparticles was dispersed in 8.9 ml of DI water, along with 100 μl of 1% 
hydroxylamine seeding agent was added and 0.5 g of dextrose. The solution pH was 
adjusted to 9.0 using 20 μl of 7% NH4OH solution. HAuCl4 aqueous solution (6.348 
mM) was added in aliquots of 100 μl to the stirred dispersion. A total of 4 injections were 
added with 10 min between each injection. The gold-coated iron oxide nanoclusters were 
separated from iron oxide only clusters by centrifugation at 6000 rpm for 6 min. The 
supernatant was decanted and the pellet was redispersed in 0.1 ml 10% dextran solution 
and 0.01 ml of a 5% polyvinyl alcohol solution to form a nanorose suspension. 
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7.3.2 Preparation of Macrophage Cell Culture and Rabbit Ar ter ial Tissues 
Macrophage cells were cultivated in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS). To load nanorose in cells, 
macrophages were incubated with nanorose suspension (3×1010 nanoroses/ml) in DMEM 
overnight and then mixed with 6% gelatin (wt/wt). Nanorose-loaded macrophages 
(2.97×106 cells/ml) and control macrophages without nanorose (2.59×106 cells/ml) were 
imaged by TPL microscopy with 800 nm excitation and TPL from macrophages was 
detected in two channels (red channel: bandpass (700/75 nm), green channel: shortpass (< 
570 nm)). 
Abdominal aortas were collected from two male double-balloon injured and fat 
fed New Zealand white rabbits: nanorose- (Positive) and saline-injected (Control) rabbits 
(Figure 7.2A). Briefly, following a two-week 0.25% cholesterol chow diet, the abdominal 
aorta was balloon injured twice and became rich in intimal hyperplasia and macrophages, 
while the thoracic aorta was not balloon injured and had little intimal hyperplasia and few 
macrophages (Figure 7.2B,C,D). The rabbits were continuously fat fed for six weeks and 
intravenously injected with nanorose (1.4 mg Au/kg) and saline respectively three days 
before sacrifice. Ex vivo abdominal aorta with macrophages were harvested, flushed 
clean of red blood cells and cut into aorta segments (8×8×2 mm3) positioned en face onto 
glass slides with the luminal side face-up for imaging as shown in Figure 2E,F. The aorta 
segments were first imaged by OCT, then pre-screened by photothermal wave (PTW) 
imaging [42] to identify “hot spots” where high concentration of nanoroses are located, 
and finally the hot spots were imaged by TPL microscopy with 800 nm excitation. All 
imaging experiments were completed within 12 hours after animal sacrifice. The animal 





Figure 7.2. A: Rabbit model of aorta inflammation with intimal hyperplasia. B: RAM-
11 staining of a cross-section of abdominal aorta. C: Amplified view of the black box in 
(B). Brown color indicates macrophages. D: RAM-11 staining of a cross-section of 
thoracic aorta. E: A piece of abdominal aorta with intimal hyperplasia. F: An aorta 
segment (8×8×2 mm3) cut from the black box in (E). 
7.3.3 Exper imental Setup 
TPL Microscopy 
TPL from nanorose was measured using a custom-built NIR laser scanning 
multiphoton microscope described previously (Figure 7.3A) [43]. A femtosecond 
Ti:Sapphire laser (Mira 900, Coherent) emitting at 800 nm (76 MHz, 300 fs) was used as 
an excitation light source. Intensity of the laser beam entering the microscope was 
modulated by an acousto-optic modulator (23080-1, NEOS Technologies) and monitored 
by a pick-off mirror (reflectance 1 %) with a photodiode calibrated for measuring the 
power delivered to the objective’s back aperture. The focal volume of the objective lens 
(20×, NA=0.95, water emersion, Olympus) was scanned over the sample in the x-y plane 
using a pair of galvanometric scanning mirrors (6215HB, Cambridge Technology) to 
produce 2-D images. TPL from the aorta segment was directed into two channels and 
detected by two photomultiplier tubes (PMT1: H7422P-40, PMT2: H7422P-50, 
Hamamatsu). To separate endogenous aorta fluorescence from nanorose luminescence, 
aorta fluorescence with emission wavelengths shorter than 570 nm was reflected by a 
long-pass filter (E570LP, Chroma Technology) and collected by PMT1 (green channel), 
while nanorose luminescence with emission wavelengths longer than 570 nm transmitted 
through a band-pass filter (HQ700/75m, Chroma Technology) and was collected by 
PMT2 (red channel). The laser power applied at cell culture and arterial tissue (ex vivo 
aorta segment and histological section) was 15 and 20 mW, respectively. No nanorose 
damage or photo-bleaching effect was observed during imaging. 
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OCT 
A swept source (SS) laser (HSL-1000, Santec) with a center wavelength of 1060 
nm and a bandwidth of 80 nm scanning at a repetition rate of 34 KHz was used in the 
custom-built intensity OCT system (Figure 7.3B). Average power incident on the sample 
arm was 1.2 mW. The measured free-space axial resolution was 20 µm with a 2.8 mm 
scan depth. The OCT signal was sampled with a linear k-space sampling clock to allow 
real-time OCT image acquisition and display. The linear k-space clock was generated by 
splitting a portion of the source light into a Mach-Zehnder interferometer and into a 
balanced detector. The clock signal was filtered, frequency-quadrupled and used as the 
input to the external clock port of the ADC card. The laser sweep rate governs the A-scan 
rate of 34 kHz and images were acquired at a rate of 68 B-scans per second with 500 A-
scans per B-scan.  
 
Figure 7.3. Schematic diagrams of (A) TPL microscopy and (B) intensity OCT 
system. 
PTW Imaging System 
A semiconductor laser (FCTS/B, Opto Power) that emits at a wavelength of 800 
nm with output power of 0.25 W was used to irradiate rabbit arterial and liver tissues to 
induce photothermal waves from nanorose. A 50 mm diameter lens (f = 40 cm) was used 
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to focus the laser beam to a 1 cm diameter spot on the tissue samples. A mechanical 
shutter intensity-modulated continuous laser light at a fixed frequency of 4 Hz with a 
50% duty cycle. The IR signal (radiometric temperature) emitted from the tissue surface 
was reflected by a dichroic mirror and recorded by an IR camera (ThermoVision SC6000 
with an InSb detector (3.0-5.0 µm), FLIR) over a 20 second time period at a frame 
acquisition rate of 25.6 Hz. The extraction of amplitude PTW images (256 × 320 pixels) 
at 4 Hz was performed by computing a fast Fourier transform (FFT) at each pixel of the 
recorded temporal IR image sequence. 
7.3.4 Histology Analysis 
Aorta sections (5 µm in thickness) were immersion-fixed in formalin, processed 
with paraffin embedding and stained with RAM-11 [44], a marker of rabbit macrophage 
cytoplasm. 
7.4  RESULTS 
7.4.1 TPL Microscopy of Nanorose-loaded Macrophages in Cell Culture 
We investigated the capability of nanorose uptake by macrophages and use of 
nanorose as an imaging contrast agent for TPL microscopy in macrophage cell culture. 
Macrophage cell cultures were selected to simulate the intimal layer of an atherosclerotic 
aorta since high concentration of macrophages in the arterial intima are characteristic of 
atherosclerotic plaques. TPL from macrophages were divided into two channels and co-
registered into a merged two-channel image (Figure 7.4). In macrophage culture with 
nanorose, strong TPL signals are detected inside macrophages in the red channel while 
much weaker TPL signal level is observed in the green channel (Figure 7.4A,B). In the 
control macrophages without nanorose no TPL signal is detected in either red or green 
channel (Figure 7.4D,E) at the same input laser power (15 mW). When TPL from 
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nanorose is detected in both red and green channels, nanorose appears yellowish red 
(Figure 7.4C). The nonlinear nature of the TPL signal was analyzed by measuring the 
dependence of the luminescence intensity as a function of laser excitation power. 
Excitation laser power was monitored by a photodiode giving the power of 13-30 mW 
delivered to the nanorose-loaded macrophages in cell culture. Luminescence intensities 
were measured by PMT2 (red channel). Figure 4G illustrates the quadratic dependence of 
luminescence intensity on the excitation laser power with a slope value of 2.07, 
confirming a TPL process. 
 
Figure 7.4. Co-registered TPL images of (A,B) nanorose-loaded macrophages and 
(D,E) control macrophages without nanorose in two channels (red and green). C,F: 
Merged two-channel images of (A,B) and (D,E) respectively. G: Quadratic dependence 
of luminescence intensity (red channel) of nanoroses in macrophage cell culture on 
excitation laser power of 13-30 mW at 800 nm. A slope of 2.07 confirms the TPL 
process. Yellow circles in (A) indicate macrophage cells. BP: band-pass (700/75 nm); SP: 
short-pass (<570 nm). 
7.4.2 Imaging Ex Vivo Rabbit Tissues 
Ex vivo segments of rabbit liver and aorta were imaged by OCT, PTW imaging 
and TPL microscopy to obtain aorta surface structure and nanorose distribution. Rabbit 
liver was selected as a positive control because liver is known to contain a high density of 
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macrophages. Several interesting findings of these imaging experiments are illustrated in 
Figure 5. Detailed surface structure of aorta segments is depicted by OCT (Figure 
7.5B,F). Peak and valley regions of the aorta surface are clearly visible in the 3-D OCT 
image. Due to strong NIR absorption by nanorose, PTW imaging is able to screen 
nanorose distribution in the whole aorta segment. High intensity PTW signals are 
observed in both abdominal aorta and liver segments (bright region Figure 7.5C,I) from 
the Positive rabbit with nanorose injection but not from the Control rabbit (Figure 
7.5G,K). Moreover, PTW signals are not observed in healthy thoracic aorta regions with 
no intimal hyperplasia from the Positive rabbit (data not shown). Due to the double-
balloon injury process, the distribution of nanorose in abdominal aorta from the Positive 
rabbit is diffusive (Figure 7.5C) with respect to the corresponding aorta surface structure 
as shown by OCT (Figure 7.5B). 
  Nanorose is also detected by TPL microscopy in the same aorta and liver 
segments from the Positive rabbit over a smaller field of view (500×500×80 µm3) as 
denoted by the red boxes in Figure 5C,I. Strong TPL signals from nanorose are observed 
(red color in Figure 7.5D,J). Nanoroses are identified to be diffusely located in lateral 
directions of the tissue segments (Figure 7.5D,J). From a side view of Figure 5D, 
nanoroses are also observed to be diffusely distributed in the axial direction along the 
luminal surface of the aorta segment within 20 µm in depth. In comparison, endogenous 
fluorescence signal detected from control aorta and liver segments is much weaker than 
nanorose TPL from the Positive rabbit at the same laser power delivered to the tissue 
(Figure 7.5H,L). Moreover, the endogenous fluorescence signal is only detected in the 
green channel, suggesting that no nanorose is identified which emits stronger TPL in the 
red channel. Insets of Figure 5D,J show a closer view of nanorose distribution with strong 
TPL signal intensity, while much higher laser powers (59 and 45 mW), respectively, were 
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needed to show the tissue structures from the Control rabbit at a similar endogenous 
fluorescence signal intensity in insets of Figure 5H,L. 
 
Figure 7.5. A,B,C,D: Digital image, 3-D OCT, PTW imaging and 3-D two-channel 
TPL microscopy (red box in (A,C)) of an abdominal aorta segment from the Positive 
rabbit. E,F,G,H: Digital image, 3-D OCT, PTW imaging and 3-D two-channel TPL 
microscopy (red box in (E,G)) of an abdominal aorta segment from the Control rabbit. 
I,J: PTW imaging and 3-D two-channel TPL microscopy (red box in (I)) of a liver 
segment from the Positive rabbit. K,L: PTW imaging and 3-D two-channel TPL 
microscopy (red box in (K)) of a liver segment from the Control rabbit. Inset in (D,H,J,L) 
shows a two-channel TPL image at a single depth at an amplified view within the 
corresponding 3-D TPL image. Right side of (D,H) shows a side view of the 
corresponding 3-D TPL image. Laser power delivered to the sample is 20 mW in all TPL 
measurements except insets of (H) 59 mW and (L) 45 mW. 
To verify that TPL signals from abdominal aorta segment from the Positive rabbit 
(Figure 7.5D) originate from nanorose-loaded macrophages, unstained histological 
sections as denoted by the black dashed lines in Figure 5A,E were cut off and imaged by 
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TPL microscopy. Sister histological sections (5 µm apart from the corresponding 
unstained sections) were stained with RAM-11. Positive RAM-11 staining of the intimal 
layer (Figure 7.6A,E) indicates presence of infiltrated macrophages in the aorta. High 
intensity TPL signals from nanorose (red color in Figure 7.6B,C,D and pointed by yellow 
arrows in Figure 7.6D) in the intimal layer co-localize with corresponding RAM-11 
staining of superficial macrophages (Figure 7.6A and inset in Figure 7.6D), suggesting 
that TPL signals in red color are generated from superficial nanorose-loaded 
macrophages. The size of nanorose aggregations in the macrophages are 1-2 µm (Figure 
7.6D). Although macrophages are observed as deep as 100 µm from luminal surface of 
the aorta, most nanoroses are detected within 20 µm (Figure 7.6D), consistent with 
nanorose distribution in the axial direction in the reconstructed 3-D TPL image of the 
same aorta segment from the Positive rabbit (side view of Figure 7.5D). This observation 
may suggest that the nanorose-loaded macrophages mostly reside in the very superficial 
regions of intima and have not migrated to deeper locations up to three days after 
intravenous nanorose injection. In contrast, in the unstained histological section from the 
Control rabbit, only endogenous fluorescence from aorta (green color) is observed in both 
superficial intima (Figure 7.6F,I) and deeper intima (Figure 7.6G,J) although dense 
accumulation of macrophages are identified with corresponding RAM-11 stain in these 
regions (Figure 7.6E).  
Endogenous fluorescence from aorta may originate from elastin fibers (pointed by 
white arrows in media layer in Figure 7.6B,H) [29,33,40]. Moreover, macrophage-like 
cellular structures with dark nuclei (indicated by yellow circles in Figure 7.6I,J) and 
possibly lipid droplets (pointed by yellow arrow heads in Figure 7.6D,J) in or outside 
macrophages are also observed [45,46]. 
 125  
 126 
Figure 7.6. A: RAM-11 stain with positive macrophage staining of the black dashed 
line in Figure 5A. B,C,D: Two-channel TPL images of the red, yellow and blue boxes in 
(A), (B) and (C) respectively. Red color indicates TPL signals from nanorose. Green 
color indicates endogenous fluorescence from aorta. Inset in (D) is a co-localized RAM-
11 stain image of (D) amplified from (A). E: RAM-11 stain with positive macrophage 
staining of the black dashed line in Figure 5E. H: TPL image of the red box in (E). F,I: 
TPL images of the yellow and blue boxes in (H) and (F) respectively. G,J: TPL images of 
the white and purple boxes in (H) and (G) respectively. Yellow arrows in (D) point to 
nanoroses. Yellow arrow heads in (D,J) point to lipid droplets. White arrows in (B,H) 
point to elastin fibers. Yellow circles in (I,J) indicate clusters of macrophage cells defined 
by dark nuclei. Laser power delivered to the sample is 20 mW. High intensity TPL 
signals from nanorose in intimal layer (B,C,D) co-localize with corresponding RAM-11 
staining of superficial macrophages in the histological section from the Positive rabbit 
(A), while no TPL signal from nanorose (red color) is observed in the histological section 
from the Control rabbit (F,G,H,I,J).  
7.5  DISCUSSION 
Nanorose was tested in macrophage cell culture as an imaging contrast agent for 
TPL microscopy. Due to a dextran coating and 30 nm particle size, a high uptake rate of 
nanorose by macrophages compared to gold nanoshells is observed and measured to be 
more than 7500 nanoroses per macrophage cell [47]. Higher TPL signal intensity is 
observed in the red channel (700/75 nm) compared to green channel (<570 nm) from the 
nanorose-loaded macrophages (Figure 7.4A,B), consistent with the TPL spectrum of 
nanorose (Figure 7.1B). Endogenous fluorescence from control macrophages without 
nanorose is not observed when the same laser power is applied (Figure 7.4D,E). In fact, 
10 times greater laser power than that used in nanorose-loaded macrophages is needed 
(data not shown) to bring endogenous fluorescence intensity from control macrophages to 
the same signal level induced by nanorose as shown in Figure 4A. 
To demonstrate the capability of TPL microscopy in combination with OCT to 
detect aorta-based macrophages, a hypercholesterolemic rabbit model of focal aorta 
inflammation induced by endothelial abrasion followed by double-balloon injury was 
utilized. The resulting injury-induced neointima in abdominal aorta was particularly rich 
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in macrophages, simulating macrophage accumulation in atherosclerotic plaques. In 
contrast to previous studies performed in animal models with diffuse atherosclerosis, this 
inflammation model allows straightforward anatomic localization of the inflammatory 
arterial lesion and a direct comparison of diseased versus normal artery portions in the 
same rabbit (Figure 7.2B,C,D) in a much shorter formation time (from 4-5 months [48] to 
10 weeks). Double-balloon injured lesions are widely spread in the aorta, consistent with 
the high accumulation and diffusive distribution of nanoroses in these areas as detected 
by TPL microscopy (Figure 7.5D and Figure 7.6B,C,D) and PTW imaging (Figure 7.5C). 
Most nanoroses are superficially detected by TPL microscopy within 20 μm from 
luminal surface of the aorta as shown in the histological section (Figure 7.6D). However, 
RAM-11 stained macrophages from corresponding sister section were distributed as deep 
as 100 μm (Figure 7.6A). This observation suggests that macrophages taking up nanorose 
are superficial in the aorta and nanoroses may migrate and then reside (no-slip condition) 
on the endothelial surface and be partially engulfed by superficial macrophages. Deeper 
in situ macrophages and macrophages that migrated into deeper locations before 
nanorose injection may not be able to take up nanorose possibly because nanorose cannot 
penetrate into the intima directly through diffusion or no nanorose is delivered through 
the vasa vasorum. In fact, vascular permeability and rate of particle (molecule or 
nanoparticle) transfer from the vascular lumen to peripheral tissue is regulated and 
limited by transcytosis of endothelial cells [49,50]. Moreover, apoptotic and necrotic 
macrophages contribute to lipid core formation in advanced atherosclerotic plaques [51]. 
These macrophage debris can stain RAM-11 positive but are not intact and would no 
longer take up nanorose in situ. 
Although nanorose uptake by macrophages has been identified in our cell culture 
study (Figure 7.4), their transport pathway to aorta-based macrophages is not elucidated. 
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Previous studies have proposed three possible mechanisms for transport of 
superparamagnetic nanoparticles to arterial tissue [52-55], including monocyte-mediated 
migration, transcytosis across the endothelium followed by uptake by in situ 
macrophages and diffusion into the adventitia via the vaso vasorum. TPL microscopy 
results of histological sections (Figure 7.6B) show that nanorose is not detected at deeper 
locations (e.g., 100-300 µm) in the aorta, indicating that nanorose diffusion via the vasa 
vasorum may not have occurred in our study. However, the relative contributions of 
monocyte-mediated migration and endothelial diffusion of nanorose remain to be 
determined. 
Simultaneous observation of macrophage distribution and plaque surface structure 
offers the ability to characterize plaque composition and identify vulnerable plaque 
regions more prone to rupture. However, several limitations need to be addressed before 
the current imaging approach can be used in patients with atherosclerosis to study the 
natural history of plaque inflammation over time and the efficacy of treatments aimed at 
plaque stabilization. First, TPL microscopy and OCT were performed in this study, 
respectively, on ex vivo tissues. An intravascular catheter is required to realize in vivo 
imaging of macrophages in plaques. Second, TPL microscopy has a smaller field of view 
than OCT in the current study. Co-registered fields of view can be achieved by coupling 
two-photon excitation light with OCT light into a catheter. Third, the penetration depth of 
TPL microscopy is shorter than OCT at current wavelength (800 nm versus 1060 nm). A 
longer wavelength for two-photon excitation will provide deeper penetration depth in 
tissue. Although the current study utilized a model of arterial wall inflammation which 
does not contain the complex nature of advanced atherosclerotic plaques, TPL 
microscopy in combination with OCT using nanorose as a contrast agent to detect 
plaque-based macrophages and assess macrophage density quantitatively is promising. 
 129 
Additional studies are required to test the capability of this combined imaging approach 
for detection of macrophages in vulnerable atherosclerotic plaques. 
7.6 CONCLUSION 
By utilizing TPL microscopy in combination with OCT we demonstrated 
detection of nanorose with respect to aorta surface structure in a double-balloon injured 
hypercholesterolemic rabbit model. Nanorose presence was also detected with PTW 
imaging. Co-localization of nanorose identified by TPL microscopy with RAM-11 
stained macrophages in the corresponding histological section suggests that TPL signal in 
the red channel (700/75 nm) is generated by superficial nanorose-loaded macrophages. 
Our results suggest that nanorose-loaded macrophages are diffusively distributed in the 
aorta and superficially located (within 20 μm from the luminal surface). This study 
indicates that combined TPL microscopy and OCT is promising for detection of aorta 
inflammation in the hypercholesterolemic rabbit using nanorose as a contrast agent. This 
combined imaging approach will need to be tested in further studies for macrophage 
detection in atherosclerotic plaques. 
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Chapter  8 Conclusions and Future Studies 
8.1  CONCLUSIONS 
The principal goal of my research is to develop hybrid optical imaging modalities: 
PTW imaging combined with OCT, TPLM combined with OCT, and assess the ability of 
such hybrid imaging modalities to reveal both cellular composition (e.g., macrophages 
(having taken up plasmonic gold nanoparticles as a contrast agent) and lipid deposits) and 
anatomical structure of atherosclerotic plaques. PTW imaging combined with OCT 
shows that superficial nanorose-loaded macrophages are distributed at shoulders on the 
upstream side of atherosclerotic plaques at edges of lipid deposits in a rabbit model of 
atherosclerosis. TPLM combined with OCT shows that nanorose-loaded macrophages are 
diffusively distributed and mostly detected superficially within 20 µm from the luminal 
surface of the aorta in a rabbit model of aorta inflammation.  
8.1.1 Measurement of Optical Proper ties of Nanorose 
In this doctoral dissertation, a gold-coated iron oxide nanoparticle cluster, 
nanorose, is used as a contrast agent to target macrophages in PTW imaging, confocal 
microscopy and TPLM. The absorption and scattering cross-sections of nanorose are 
determined from a direct optical properties measurement and a DDA simulation. 
Experiment indicates that absorption cross-section is σa = (3.1 ± 0.5) × 10-14 m2. DDA 
results indicate that nanorose absorption cross-section is an order of magnitude larger 
than the scattering cross-section (Chapter 3).  
8.1.2 Dual-wavelength Multi-frequency PTW Imaging Combined with OCT for 
Macrophage and Lipid Detection in Atherosclerotic Plaques Using Gold 
Nanopar ticles  
PTW imaging was first investigated to detect nanorose-loaded macrophages in 
atherosclerotic plaques. By utilizing PTW imaging in response to 800 and 1210 nm laser 
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irradiation we demonstrated detection of PTW signals from nanorose and lipid deposits in 
atherosclerotic plaques. Moreover, multi-frequency (0.1, 1 and 4 Hz) PTW imaging can 
be used to distinguish nanorose and lipid deposits distributed at different depths. 
Nanorose presence was also identified with TPL microscopy in histological sections. Co-
localization of nanorose in TPL microscopy images with RAM-11 stained macrophages 
suggests that PTW signals at 800 nm laser irradiation is generated by superficial 
nanorose-loaded macrophages. Amplitude PTW images (800 and 1210 nm) at a 
modulation frequency of 4 Hz merged with a co-registered OCT image demonstrated the 
location and distribution of superficial nanorose-loaded macrophages and lipid deposits 
with respect to plaque surface structure and direction of blood flow. Our results suggest 
that nanorose-loaded macrophages are distributed at plaque shoulders on the upstream 
side, at edges of lipid deposits, and superficially located (within 20 μm from plaque 
surface). This ex vivo animal study suggests that combined PTW-OCT imaging is a 
promising approach for multi-depth screening of nanorose-loaded macrophages and lipid 
deposits in atherosclerotic plaques (Chapters 4 and 6). 
8.1.3 Combined TPLM and OCT for Macrophage Detection in the 
Hypercholesterolemic Rabbit Aor ta Using Plasmonic Gold Nanorose  
TPLM has been employed to detect aorta components such as nanorose-loaded 
macrophages, elastin fibers and lipid droplets. By utilizing TPLM in combination with 
OCT we demonstrated detection of nanorose with respect to aorta surface structure in a 
double-balloon injured hypercholesterolemic rabbit model. Nanorose presence was also 
detected with PTW imaging. Co-localization of nanorose identified by TPLM with RAM-
11 stained macrophages in the corresponding histological section suggests that TPL 
signal in the red channel (700/75 nm) is generated by superficial nanorose-loaded 
macrophages. Results suggest that nanorose-loaded macrophages are diffusively 
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distributed in the aorta and superficially located (within 20 μm from the luminal surface). 
This study indicates that combined TPLM and OCT is promising for detection of aorta 
inflammation in the hypercholesterolemic rabbit using nanorose as a contrast agent. This 
combined imaging approach will need to be tested in further studies for macrophage 
detection in atherosclerotic plaques (Chapter 7). 
8.2  FUTURE STUDIES 
8.2.1 3-D Reconstruction Algor ithm for  Swept-frequency PTW Imaging 
The 3-D reconstruction algorithm employed in swept-frequency PTW imaging 
(Chapter 4) is a direct reconstruction from a stack of PTW amplitude/phase image slices 
from high to low frequencies (i.e., 5-0.04 Hz). However, because each slice contains 
chromophore information from slices above (higher frequencies than the current slice), a 
“layer stripping” algorithm may need to be applied to eliminate the effect from overlying 
layers, which will be able to provide a more accurate depiction of 3-D distributions of 
chromophores. 
8.2.2 Optimization of Imaging Contrast Agent 
Nanorose has been utilized as a contrast agent for TPLM to target macrophages. 
Nanorose specificity is achieved since endogenous fluorescence emission (at 800 nm 
excitation) of collagen, elastin fibers, oxidized-LDL, calcification and lipid are all below 
650 nm while TPL emission of nanorose is broad and emission intensity increases beyond 
this wavelength. To optimize TPL emission in response to an  800 nm excitation 
wavelength, new nanoroses (more precisely, gold nanoparticle cluster) with different 
geometries (Figure 8.1) need to be tested to determine the cluster formulation with 
brightest average TPL signals.  
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Figure 8.1. Nanorose geometries (imaged by TEM) for optimizing two-photon 
absorption and luminescence. Scale Bar: 50 nm. 
8.2.3 Realization of Intravascular  Imaging of Atherosclerotic Plaques 
The vulnerable plaque, recently defined by Virmani as “thin-cap fibroatheroma”, 
results from inflammation and is characterized as having a thin fibrous cap typically less 
than 65 µm thick, increased infiltration of macrophages with decreased smooth muscle 
cells, and an increased lipid core size compared to stable plaques. 
Intravascular OCT (IVOCT) is a recently developed catheter-based method for 
high-resolution intravascular imaging. Currently, of all cardiovascular imaging 
modalities, IVOCT is the sole approach that provides sufficient spatial resolution to 
image thin-cap fibroatheromas. Thomas Milner, PhD and colleagues have constructed an 
IVOCT system with an OCT catheter for imaging human coronary arteries. Thin-cap 
fibroatheromas overlying large lipid cores can be identified (Figure 8.2). 
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Figure 8.2. IVOCT images of a cross-section of a human coronary artery. (A) Thin-
cap fibroatheroma overlying a large lipid core is observed at the 1:00-3:00 O’Clock 
position. (B) A healthy coronary artery. Reconstructed side view of the artery along the 
white line during a pullback is shown at the bottom of (A) and (B). 
 However, risk of plaque rupture cannot be easily assessed by only IVOCT 
because of the difficulties to distinguish macrophages from lipids and other plaque 
components such as crystals of cholesterol esters and microcalcifications due to poor 
scattering contrast between them. Therefore, further studies to combine IVOCT with TPL 
imaging and design a co-registered OCT-TPL imaging catheter to simultaneously image 
thin-cap fibroatheromas and macrophages (having taken up gold nanoparticles) with high 
spatial resolution will have decided advantages over IVOCT alone and will provide 
cardiologists important information about the vulnerability of thin-cap fibroatheromas.
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